Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Oral Oncol
    December 2024
  1. ESPEROUZ F, Caponio VCA, Santarelli A, Ballini A, et al
    Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequential analysis.
    Oral Oncol. 2024;159:107104.
    >> Share

  2. PANG P, Xue X, Xu Z, Duan W, et al
    Functional reconstruction of lip defects.
    Oral Oncol. 2024;159:107055.
    >> Share

  3. GENSTERBLUM-MILLER E, Bhangale A, Majid DA, Pienkowski VM, et al
    Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma.
    Oral Oncol. 2024;159:107108.
    >> Share

  4. SANKAR GANESH P, Naseef Pathoor N, Kanna Gopal R
    Letter to the editor regarding, "Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma".
    Oral Oncol. 2024;159:107091.
    >> Share

  5. VIEIRA SH, Vidoris AAC, Matos LL
    Metastasis to the ciliary body and iris from a parotid carcinoma.
    Oral Oncol. 2024;159:107098.
    >> Share

  6. PENG H, Zhang LY, Zhu WZ, Zhou Y, et al
    Innovative use of radial artery retrograde forearm flap for oral and maxillofacial reconstruction.
    Oral Oncol. 2024;159:107084.
    >> Share

  7. WANG X, Chen X, Mei Z
    Changes of immune function mediated by Gasdermin-E in the immune microenvironment of primary oral squamous cell carcinoma.
    Oral Oncol. 2024;159:107088.
    >> Share

  8. RITSCHL LM, Sackerer V, Pippich K, Zink JK, et al
    Impact of tumor localization and choice of microvascular flap on posterior airway changes following ablative surgery in primary oral squamous cell carcinoma: A monocentric cross-sectional study.
    Oral Oncol. 2024;159:107080.
    >> Share

  9. KLIBNGERN H, Kang CJ, Lee LY, Ng SH, et al
    Margin-to-depth ratio as an independent prognostic factor in resected oral cavity squamous cell carcinoma: A nationwide cohort study.
    Oral Oncol. 2024;159:107102.
    >> Share

  10. NIELSEN SB, Holm Larsen MH, Channir HI, Kiss K, et al
    The value of tongue base mucosectomy in the work-up of squamous cell carcinoma of unknown primary: A Danish national cohort study.
    Oral Oncol. 2024;159:107083.
    >> Share

  11. PELAEZ-PRESTEL HF, Gonzalez-Martin F, Ras-Carmona A, Rocha A, et al
    Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25(+)CD163(+)CD206(+) macrophages.
    Oral Oncol. 2024;159:107078.
    >> Share

  12. POISSONNET V, Chabrillac E, Uro-Coste E, Woisard V, et al
    Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study.
    Oral Oncol. 2024;159:107072.
    >> Share

  13. ICHIMURA N, Urata Y, Kobayashi T, Ebata R, et al
    Mutational landscape of Japanese patients with oral squamous cell carcinoma from comprehensive genomic profiling tests.
    Oral Oncol. 2024;159:107079.
    >> Share

  14. DE BIASIO MJ, Mohan R, Hendler A, Jillian Tsai C, et al
    Lymphatic mapping in second primary or recurrent oral cavity cancer with prior neck treatment: A case series and scoping review.
    Oral Oncol. 2024;159:107077.
    >> Share

  15. HARRIS MK, Dang S, Smith JD, Chinn S, et al
    Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction.
    Oral Oncol. 2024;159:107076.
    >> Share

  16. BALAJI H, Aithal VU, Varghese JJ, Devaraja K, et al
    Agreement between patient-reported and clinician-rated speech and swallowing outcomes - Understanding the trend in post-operative oral cavity cancer patients.
    Oral Oncol. 2024;159:107068.
    >> Share

  17. HEFT NEAL ME, Smith JD, Lyden TH, Chanowski EJP, et al
    Oral cavity obliteration is a novel predictor of functional outcomes after glossectomy reconstruction.
    Oral Oncol. 2024;159:107058.
    >> Share

  18. BALAGURU L, Hanubal KS, Galochkina Z, Lee JH, et al
    Surgical and functional outcomes after salvage oropharyngectomy.
    Oral Oncol. 2024;159:107050.
    >> Share

  19. KORIC A, Chang CP, Hu S, Snyder J, et al
    Oral health-related quality of life among oropharyngeal cancer survivors.
    Oral Oncol. 2024;159:107062.
    >> Share

  20. BOZKURT G, Turri Zanoni M, Ferrari M, Ioppi A, et al
    Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors.
    Oral Oncol. 2024;159:107048.
    >> Share

  21. LIAN H, Hua Y, Paka Lubamba G, Zhang G, et al
    Reconstruction of extensive lower lip defects using vascularized mucosal flap with external skin complex tissue.
    Oral Oncol. 2024;159:107056.
    >> Share

  22. KIM JY, Kim Y, Kim EH, Chung MK, et al
    Initial negative resection margin versus revised negative resection margin in patients who underwent surgery without adjuvant therapy for early-stage oral tongue squamous cell carcinoma.
    Oral Oncol. 2024;159:107046.
    >> Share

  23. PEREZ-DE-OLIVEIRA ME, Wagner VP, Bingle CD, Vargas PA, et al
    Disruption of oncogenic pathways in mucoepidermoid carcinoma: CREB inhibitor 666.15 as a potential therapeutic agent.
    Oral Oncol. 2024;159:107029.
    >> Share

  24. AL AFIF A, Rosen P, Gardella J, Norwood TG, et al
    Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores.
    Oral Oncol. 2024;159:107045.
    >> Share

  25. MAHTO K, Kumar Goldar G, Varshney A, Malhotra M, et al
    Achieving negative superficial resection margins with NBI and white light in carcinoma oral cavity: Could it be a norm?
    Oral Oncol. 2024;159:107044.
    >> Share

  26. MA L, Li C
    Da Vinci robot-assisted surgery for deep lobe of parotid benign tumor via retroauricular hairline approach: Exploration of a new surgical method for parotid tumors.
    Oral Oncol. 2024;159:107043.
    >> Share

  27. HUANG NS, Chen JY, Meng Y, Li QL, et al
    Pralsetinib as neoadjuvant therapy for RET-Altered differentiated thyroid cancer: Two case reports.
    Oral Oncol. 2024;159:107014.
    >> Share

  28. DANIELS KE, Awad DR, Liu SX, Mocharnuk J, et al
    Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2024;159:107031.
    >> Share

  29. GREEN L, McDowell L, Ip F, Tapia M, et al
    Early return to work is possible after transoral robotic surgery (TORS) in carefully selected patients with oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2024;159:107032.
    >> Share

  30. LU YT, Lin CW, Su SC, Ho YT, et al
    L48H37, a curcumin analog, suppresses matrix metalloproteinase-9 expression and activity to hamper nasopharyngeal cancer cell migration.
    Oral Oncol. 2024;159:107038.
    >> Share

  31. STAIBANO P, Au M, Xie M, Gupta MK, et al
    Return to work and self-reported swallowing following transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort study.
    Oral Oncol. 2024;159:107033.
    >> Share

  32. CLEERE EF, Hintze JM, Doherty C, Timon CVI, et al
    The association of frailty with morbidity and mortality following major mucosal head and neck surgery.
    Oral Oncol. 2024;159:107021.
    >> Share

    November 2024
  33. MARRET G, Lamy C, Vacher S, Cabel L, et al
    Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.
    Oral Oncol. 2024;160:107111.
    >> Share

  34. JEYARAJ G
    Letter to the editor, "Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.".
    Oral Oncol. 2024;160:107092.
    >> Share

  35. LIU Y, Fu N, Liu H, Su S, et al
    Risk factors of lymph node metastasis in the diffuse sclerosing variant of papillary thyroid carcinoma compared with conventional papillary thyroidcarcinoma in pediatric populations.
    Oral Oncol. 2024;160:107120.
    >> Share

  36. YAN C, Wang R, Zhang C, Lin G, et al
    Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF.
    Oral Oncol. 2024;160:107119.
    >> Share

  37. VON WITZLEBEN A, Grages A, Thomas J, Ezic J, et al
    Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) - A single-cell RNA sequencing analysis.
    Oral Oncol. 2024;159:107107.
    >> Share

  38. LI S, Zhao T, Liu N, Li Y, et al
    Global research on oral cancer: A bibliometric analysis based on 82 highly cited publications from 2014 to 2024.
    Oral Oncol. 2024;159:107094.
    >> Share

  39. YANG B, Dai X, Li Z, Wu Z, et al
    Noninvasive surface-enhanced Raman spectroscopy outperforms combined positive score in predicting sensitivity to neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
    Oral Oncol. 2024;159:107105.
    >> Share

  40. RENGASAMY G, Priya Veeraraghavan V
    Using salivary DNA methylation to predict aging, cell changes, and protein levels for assessing oral mucositis severity and survival in head and neck cancer patients.
    Oral Oncol. 2024;159:107086.
    >> Share

  41. LEE YC, Hsin LJ, Lin WN, Fang TJ, et al
    Robot-assisted versus conventional neck dissection in head and neck cancers: A systematic review and meta-analysis.
    Oral Oncol. 2024;159:107101.
    >> Share

  42. MORGENTHALER J, Trommer M, Khor R, Wada M, et al
    Can we safely de-escalate HPV(+) oropharyngeal cancers? - A review of current practices and novel approaches.
    Oral Oncol. 2024;159:107089.
    >> Share

  43. LENNON SILVA CUNHA J
    In reply to "Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study".
    Oral Oncol. 2024;159:107096.
    >> Share

  44. TOPKAN E, Somay E, Ozturk D, Selek U, et al
    Commentary on "Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions".
    Oral Oncol. 2024;159:107099.
    >> Share

  45. SHANG K, Li T, Chen Y, Luo X, et al
    Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial.
    Oral Oncol. 2024;159:107087.
    >> Share

  46. COSTANTINO A, Haughey B, Alamoudi U, Magnuson JS, et al
    Challenges in treating oropharyngeal cancer in the elderly: The role of transoral surgery.
    Oral Oncol. 2024;158:106996.
    >> Share

  47. DE LIMA-SOUZA RA, Ferreira IV, Chone CT, Egal ESA, et al
    Secretory carcinoma of the minor salivary gland: An in-depth case report.
    Oral Oncol. 2024;158:107005.
    >> Share

  48. WEI Y, Xiao L, Liu L, Shi L, et al
    Prognostic implications of lymph node yield in pediatric patients with N1b papillary thyroid cancer.
    Oral Oncol. 2024;158:106984.
    >> Share

  49. SOLARZ P, Mackiewicz-Nartowicz H, Sinkiewicz A, Burduk P, et al
    Results of CO2 laser surgery in laryngeal papillomatosis.
    Oral Oncol. 2024;158:107004.
    >> Share

  50. ASHIQUE S, Houshyari M, Islam A, Pal R, et al
    The role of microbiota in nasopharyngeal cancer: Where do we stand?
    Oral Oncol. 2024;158:106982.
    >> Share

  51. DE SENA COSTA DE OLIVEIRA D, Cunha JLS
    Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients.
    Oral Oncol. 2024;159:107097.
    >> Share

  52. HIMANI
    Letter to the editor: Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990-2021.
    Oral Oncol. 2024;159:107093.
    >> Share

    October 2024
  53. MUTHAMIZH S, Balachandran S, Dilipan E
    Opinion on "Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma".
    Oral Oncol. 2024;159:107095.
    >> Share

  54. LEHYANTI J, Even C, Fessart E, Wagner-Ballon C, et al
    Management of oligometastatic head and neck squamous cell carcinoma: A systematic review.
    Oral Oncol. 2024;159:107085.
    >> Share

  55. VILLARME A, Ebran N, Pace-Loscos T, Schiappa R, et al
    Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2024;159:107082.
    >> Share

  56. KARAMCHANDANI S, Sahovaler A, Crosbie-Jones E, McGurk M, et al
    Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer.
    Oral Oncol. 2024;159:107081.
    >> Share

  57. LI D, Lopez A, Shrivastava N, Chan W, et al
    Comprehensive functional evaluation of head and neck squamous cell carcinoma with BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of BH3-mimetics.
    Oral Oncol. 2024;159:107069.
    >> Share

  58. WU WB, Xia L, Feng ZK, Liang JL, et al
    Characteristics and treatment of epistaxis in nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107071.
    >> Share

  59. ZANG Y, Lu Y, Yu J, Dong Q, et al
    FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107066.
    >> Share

  60. GARSET-ZAMANI M, Lomholt AF, Charabi BW, Norling R, et al
    Surgeon-performed intraoperative transoral ultrasound improves the detection of human papillomavirus-positive head and neck cancers of unknown primary.
    Oral Oncol. 2024;159:107073.
    >> Share

  61. LIU C, Zhao H, Lu Y, Xia Y, et al
    Nomograms to predict occult contralateral central lymph node metastases in unilateral papillary thyroid carcinoma with ipsilateral clinical lymph node metastasis.
    Oral Oncol. 2024;159:107051.
    >> Share

  62. SONG Y, Zhang Y, Bai Y, Wang T, et al
    Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study.
    Oral Oncol. 2024;159:107067.
    >> Share

  63. AWEEDA M, Richard K, Arnaud EH, Divi V, et al
    Factors influencing lymph node yield in head and neck squamous cell carcinoma: A scoping review.
    Oral Oncol. 2024;159:107070.
    >> Share

  64. HE SQ, Liu GY, Yu YH, Wang L, et al
    Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort study.
    Oral Oncol. 2024;159:107074.
    >> Share

  65. LEE RH, Evans C, Alqasieer Y, Knott PD, et al
    Bite me: Can active biting during trismus therapy improve mouth opening in head and neck cancer patients?
    Oral Oncol. 2024;159:107064.
    >> Share

  66. ZHAO BY, Hirayama S, Goss D, Zhao Y, et al
    Human papillomavirus-associated nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2024;159:107057.
    >> Share

  67. TANG WZ, Xu WZ, Liu TH
    Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107065.
    >> Share

  68. YACOUB I, Qian JY, Nashed K, Youssef M, et al
    Radiation techniques and advancements in nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107060.
    >> Share

  69. GAUDIOSO P, Contro G, Taboni S, Costantino P, et al
    Intraoperative surgical navigation as a precision medicine tool in sinonasal and craniofacial oncologic surgery.
    Oral Oncol. 2024;157:106979.
    >> Share

  70. SCHEMEL AF, Manosalva RE, Pataroque D, Keirns D, et al
    Shortcomings of excisional biopsy in Early-Stage oral cavity carcinoma.
    Oral Oncol. 2024;157:106909.
    >> Share

  71. SMITH B, Rosko A, VanKoevering KK, Heft Neal M, et al
    3D modeling of anterior 2/3rds glossectomy reconstruction: A volume based donor site evaluation.
    Oral Oncol. 2024;157:106960.
    >> Share

  72. CABEZAS-CAMARERO S, Perez-Segura P, Riquelme A, Roman-Garcia J, et al
    Profound ctDNA and radiological responses after 2 cycles of avelumab in a metastatic Merkel cell carcinoma of the head and neck.
    Oral Oncol. 2024;157:106971.
    >> Share

  73. TAMIL SELVAN S
    Letter to the editor "A phase 1 study of concurrent cabozantinib and cetuXimab in recurrent or metastatic head and neck squamous cell cancer".
    Oral Oncol. 2024;157:106958.
    >> Share

  74. TOPKAN E, Somay E, Selek U
    Comment on the effect of treatment package time on locally advanced oral cavity cancer outcomes (https://doi.org/10.1016/j.oraloncology.2024.106870).
    Oral Oncol. 2024;157:106961.
    >> Share

  75. MA Z, Ding Z, Tang H, Guo Z, et al
    Current Challenges and Requirements in Robotic Head and Neck Surgery.
    Oral Oncol. 2024;157:106956.
    >> Share

  76. FARLOW JL, McCrary HC, Meeker M, Alexander J, et al
    The osteocutaneous radial forearm free flap: A multidisciplinary review of the evidence.
    Oral Oncol. 2024;157:106925.
    >> Share

  77. CONTRERA KJ, Mahomva CR, Sharma BK, Wei W, et al
    Patterns of failure after salvage head and neck surgery.
    Oral Oncol. 2024;157:106957.
    >> Share

  78. DAWSON A, Karimi AH, Shaikh MH, Gazala W, et al
    Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.
    Oral Oncol. 2024;159:107061.
    >> Share

  79. AKASHANAND, Zahiruddin QS, Jena D, Ballal S, et al
    Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990-2021.
    Oral Oncol. 2024;159:107063.
    >> Share

    September 2024
  80. LECHIEN JR
    Surgical, Functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal Cancers: A systematic review.
    Oral Oncol. 2024;159:107047.
    >> Share

  81. KEEFE K, McCrary HC, Wei M, Mark B, et al
    Risk of cardiovascular disease among head and neck cancer survivors: A population-based matched cohort study.
    Oral Oncol. 2024;159:107041.
    >> Share

  82. DHARSHINI RAJATHIRAJAN S
    Commentary on "Salivary DNA methylation derived estimates of biological aging, cellular frequency and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients".
    Oral Oncol. 2024;159:107053.
    >> Share

  83. LYU W, Gong J, Zhu L, Xu T, et al
    MR radiomics unveils neoadjuvant chemo-responsiveness with insights into selective treatment de-intensification in HPV-positive oropharyngeal carcinoma.
    Oral Oncol. 2024;159:107049.
    >> Share

  84. PRITHVIRAJ
    Comment on "Sexual Health, sexuality and sexual intimacy in patients with head and neck cancer".
    Oral Oncol. 2024;159:107054.
    >> Share

  85. DINESHKUMAR R
    Letter to the editor: Risk factors associated with ototoxicity in long-term survivors of nasopharyngeal carcinoma.
    Oral Oncol. 2024;159:107052.
    >> Share

  86. VALCENKO A, Zwick A, Schneider L, Linxweiler M, et al
    The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotype.
    Oral Oncol. 2024;159:107042.
    >> Share

  87. MIN Y, Liu X, Wei Z, Song G, et al
    Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.
    Oral Oncol. 2024;159:107028.
    >> Share

  88. RENGASAMY G, Priya Veeraraghavan V
    Comment on "The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-) radiotherapy".
    Oral Oncol. 2024;159:107035.
    >> Share

  89. DHARSHINI RAJATHIRAJAN S
    Commentary on "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression.".
    Oral Oncol. 2024;159:107037.
    >> Share

  90. DHARSHINI RAJATHIRAJAN S
    Commentary on "Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients".
    Oral Oncol. 2024;159:107036.
    >> Share

  91. VERSCHOOR CP, Santi SA, Singh R, Tharmalingam S, et al
    Salivary DNA methylation derived estimates of biological aging, cellular frequency and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients.
    Oral Oncol. 2024;159:107030.
    >> Share

  92. PAKA LUBAMBA G, Hua Y, Bao M, Zhang G, et al
    Variant of internal jugular vein reconstruction in bilateral radical neck dissection.
    Oral Oncol. 2024;159:107015.
    >> Share

  93. WANG A, Xia H, Li J, Diao P, et al
    Development of a novel prognostic signature derived from super-enhancer-associated gene by machine learning in head and neck squamous cell carcinoma.
    Oral Oncol. 2024;159:107016.
    >> Share

  94. PRITHVIRAJ T
    Commentary on "Tumor Habitat-Based MRI features assessing early response in locally advanced nasopharyngeal carcinoma".
    Oral Oncol. 2024;159:107018.
    >> Share

  95. XIAOYU J, Baihong P, Yaozhen L, Shen C, et al
    Preoperative protective stenting of the carotid artery in severe complex head and neck cancer resection.
    Oral Oncol. 2024;158:107012.
    >> Share

  96. PAYNE K, Suriyanarayanan H, Brooks J, Mehanna H, et al
    Exploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free DNA methylation and copy number in head and neck squamous cell carcinoma.
    Oral Oncol. 2024;158:107011.
    >> Share

  97. ZHANG X, Zheng W, Huang S, Li H, et al
    Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models.
    Oral Oncol. 2024;158:107000.
    >> Share

  98. JEYACHANDRAN S
    Comment on, "Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date".
    Oral Oncol. 2024;156:106955.
    >> Share

  99. SUDHAKARAN G
    Letter to editor: Comment on "Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation".
    Oral Oncol. 2024;156:106953.
    >> Share

  100. SELVAN ST
    Letter to the editor "Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice".
    Oral Oncol. 2024;156:106943.
    >> Share

  101. CHEN J, Cheng H, Liang Y, Lin J, et al
    The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads.
    Oral Oncol. 2024;156:106938.
    >> Share

  102. BALASAMY S, Sundramoorthy AK
    Comment on "Utilizing deep learning for automated detection of oral lesions: A multicenter study".
    Oral Oncol. 2024;156:106932.
    >> Share

  103. YANG Q, Guo B, Zheng Y
    Comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis.
    Oral Oncol. 2024;156:106839.
    >> Share

  104. GALLANT JN, Vivek N, McKeon MG, Sharma RK, et al
    Establishing a role for the oral microbiome in infectious complications following major oral cavity cancer surgery.
    Oral Oncol. 2024;156:106926.
    >> Share

  105. KAMALAKKANNAN S, Rajan F, Shanmugam J, Ramachandran S, et al
    Margin status, adjuvant treatment and recurrence in buccal cancer.
    Oral Oncol. 2024;156:106927.
    >> Share

  106. SATHISHKUMAR K
    Letter to the editor "Survival patterns and prognostic factors of gingivobuccal complex squamous cell cancer: A monocentric retrospective chart audit".
    Oral Oncol. 2024;156:106914.
    >> Share

  107. TOMAR A, Kaushal Jain H
    Extraskeletal ewing's sarcoma on hard palate biltaerally: A rare case report.
    Oral Oncol. 2024;156:106916.
    >> Share

  108. ROSEN R, Bodnar M, Randolph J, Bailey CJ, et al
    Risk, prevention, screening and management of carotid artery stenosis in head & neck cancer patients-An evidence based review.
    Oral Oncol. 2024;156:106876.
    >> Share

    August 2024
  109. LECHIEN JR, Hans S
    Survival, Surgical, and functional outcomes of transoral laser microsurgery for cT1-T3 supraglottic laryngeal Cancers: A systematic review.
    Oral Oncol. 2024;158:107009.
    >> Share

  110. ZHAO J, Ruan X, Wei S, Zheng X, et al
    The first report of bilateral parapharyngeal lymph node metastasis from papillary thyroid carcinoma: A case report.
    Oral Oncol. 2024;158:107006.
    >> Share

  111. YIN WJ, Mao W, Yang F, Wang MY, et al
    Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions.
    Oral Oncol. 2024;158:107001.
    >> Share

  112. GE Y, Liu H, Huang W, Zhu H, et al
    Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1(hi) and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment.
    Oral Oncol. 2024;158:106999.
    >> Share

  113. T P
    Commentary on "Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/mHNSCC)".
    Oral Oncol. 2024;158:107010.
    >> Share

  114. ZHOU X, Shao T, Jia H, Hou L, et al
    Current state, challenges, and future perspective of adaptive radiotherapy: A narrative review of nasopharyngeal carcinoma.
    Oral Oncol. 2024;158:107008.
    >> Share

  115. PRASAD M
    DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer.
    Oral Oncol. 2024 Aug 23:106995. doi: 10.1016/j.oraloncology.2024.106995.
    >> Share

  116. KNAP RABJERG H, Grau Eriksen J, Soby S
    Impact of antibiotics on PD-1 inhibition in recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2024;158:107003.
    >> Share

  117. DU F, Shao K, Yang Y, Bai X, et al
    Comparative dosimetric analysis of normal brain tissue in patients with Nasopharyngeal carcinoma at different stages after radiation therapy.
    Oral Oncol. 2024;158:106998.
    >> Share

  118. ALSHEIKH S, Su J, O'Sullivan B, Ringash J, et al
    The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-)radiotherapy.
    Oral Oncol. 2024;158:107007.
    >> Share

  119. SUN L, Cohen RB, Dimitrios Colevas A
    Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC).
    Oral Oncol. 2024;158:106997.
    >> Share

  120. HANNA GJ, Jabalee J, Lukens JN, Sun L, et al
    Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer.
    Oral Oncol. 2024;158:107002.
    >> Share

  121. YUAN J, Wu M, Qiu L, Xu W, et al
    Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2024;158:106980.
    >> Share

  122. YANG R, Li R, Niu X, Zhao Y, et al
    Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study.
    Oral Oncol. 2024;158:106981.
    >> Share

  123. HUSSEIN NI, Molina AH, Sunga GM, Amit M, et al
    Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders.
    Oral Oncol. 2024;158:106986.
    >> Share

  124. PAN GS, Sun XM, Kong FF, Wang JZ, et al
    Delta magnetic resonance imaging radiomics features?based nomogram predicts long?term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2024;157:106987.
    >> Share

  125. QIN G, Liao X, Zhang B, Su Y, et al
    An individualized immune prognostic signature in nasopharyngeal carcinoma.
    Oral Oncol. 2024;157:106985.
    >> Share

  126. TAMIOLAKIS P, Shah A, Dawson R, Ramasamy S, et al
    HPV- associated sinonasal squamous cell carcinoma with FGFR3::TACC3 fusion. A rare case report.
    Oral Oncol. 2024;157:106983.
    >> Share

  127. SHIMIZU H, Kodaira T, Kiyota N, Hayashi R, et al
    Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008.
    Oral Oncol. 2024;157:106976.
    >> Share

  128. SANKAR S
    Letter to editor regarding "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression".
    Oral Oncol. 2024;157:106977.
    >> Share

  129. SCHAEFFERS AWMA, Scholten HA, van Beers MA, Meussen BW, et al
    The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis.
    Oral Oncol. 2024;157:106978.
    >> Share

  130. RAJA K
    Comments on "Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses".
    Oral Oncol. 2024;155:106897.
    >> Share

  131. BEEGUM F, Trimukhe AC, Nayanar SK, Attakkil A, et al
    Need for clarification on pathological tumor size for lip and oral cavity cancers with size 10 mm: A letter to the editor.
    Oral Oncol. 2024;155:106900.
    >> Share

  132. KHAN M
    Commentary on "Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019".
    Oral Oncol. 2024;155:106905.
    >> Share

  133. SHANMUGAM G
    Letter to the editor, "Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma.".
    Oral Oncol. 2024;155:106892.
    >> Share

  134. ZAGARDO V, Pergolizzi S, Ferini G
    Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy.
    Oral Oncol. 2024;155:106880.
    >> Share

  135. MADHUMITHA M, Dharmalingam Jothinathan MK
    Letter to the editor, "Personal immune profiles: Diversity and prognostic values for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.".
    Oral Oncol. 2024;155:106872.
    >> Share

  136. PATHOOR NN, Ganesh PS
    Letter to the editor regarding, "Beneath the surface: A systematic review on intraoperative imaging techniques for deep margin assessment in oral squamous cell carcinoma".
    Oral Oncol. 2024;155:106871.
    >> Share

  137. YE YJ, Han Y, Liu Y, Guo ZL, et al
    Utilizing deep learning for automated detection of oral lesions: A multicenter study.
    Oral Oncol. 2024;155:106873.
    >> Share

    July 2024
  138. MCDOWELL L, Gough K, White I, Corry J, et al
    Sexual Health, sexuality and sexual intimacy in patients with head and neck cancer - A narrative review.
    Oral Oncol. 2024;157:106975.
    >> Share

  139. DAS S, Ghosh Laskar S, V Kane S, D'Cruz AK, et al
    Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?
    Oral Oncol. 2024;157:106972.
    >> Share

  140. JEYARAJ G
    Letter to the editor, "Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the head and neck Cancer Registry of Japan.".
    Oral Oncol. 2024;157:106974.
    >> Share

  141. JEYARAJ G
    Letter to the editor, "Mutation detection in saliva from oral cancer patients".
    Oral Oncol. 2024;157:106929.
    >> Share

  142. GANESH PS, Pathoor NN, Gopal RK
    Letter to the editor regarding "Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
    Oral Oncol. 2024;157:106954.
    >> Share

  143. LORINI L, Zigliani G, Morbini P, Salviato E, et al
    Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study).
    Oral Oncol. 2024;157:106950.
    >> Share

  144. JEYACHANDRAN S
    Comment on, "Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes".
    Oral Oncol. 2024;157:106973.
    >> Share

  145. SURESH S
    Comment on: An algorithm for standardization of tumor infiltrating lymphocyte evaluation in head and neck cancers.
    Oral Oncol. 2024;157:106959.
    >> Share

  146. WEN YF, Huang WJ, Chen XL, Cai HT, et al
    Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients.
    Oral Oncol. 2024;157:106963.
    >> Share

  147. ICHISAKA T, Sano D, Kijima N, Kawakita D, et al
    Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the Head and Neck Cancer Registry of Japan.
    Oral Oncol. 2024;157:106942.
    >> Share

  148. TINO R, Roach MA, Fuentes GD, Agrawal A, et al
    Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy.
    Oral Oncol. 2024;157:106944.
    >> Share

  149. LIM CY, Ng GWY, Goh CK, Lee MKC, et al
    Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression.
    Oral Oncol. 2024;157:106941.
    >> Share

  150. SHANMUGAM G
    Letter to the editor, "The prognostic value of pretreatment (18)F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.".
    Oral Oncol. 2024;157:106951.
    >> Share

  151. MEIVELU MOOVENDHAN
    "Letter to the Editor: Next-Generation sequencing (NGS) profiling of matched tumor and Circulating Tumor DNA (ctDNA) in Head and Neck Squamous Cell Carcinoma (HNSCC)".
    Oral Oncol. 2024;157:106940.
    >> Share

  152. ZENGA J, Himburg HA, Wong SJ, Kearl T, et al
    In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations.
    Oral Oncol. 2024 Jul 14:106947. doi: 10.1016/j.oraloncology.2024.106947.
    >> Share

  153. DHARMALINGAM JOTHINATHAN MK
    Letter to the Editor, "Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma".
    Oral Oncol. 2024;156:106948.
    >> Share

  154. SHANMUGAM G
    Commentary on, "Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.".
    Oral Oncol. 2024;156:106952.
    >> Share

  155. PIYARATHNE NS, Liyanage SN, Rasnayaka RMSGK, Hettiarachchi PVKS, et al
    A comprehensive dataset of annotated oral cavity images for diagnosis of oral cancer and oral potentially malignant disorders.
    Oral Oncol. 2024;156:106946.
    >> Share

  156. KIM H, Roh T, Banegas DW, Cha IH, et al
    Is immediate dental implant in fibula free flap beneficial for implant survival and osteoradionecrosis in jaw reconstruction?
    Oral Oncol. 2024;156:106945.
    >> Share

  157. MAHDI AGM
    Knowledge, and attitude of medical students about role of human papilloma virus, and vaccine in head and neck cancer.
    Oral Oncol. 2024;156:106939.
    >> Share

  158. SHANMUGAM G
    Letter to the editor, "Letter to the editor, "Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.".
    Oral Oncol. 2024;156:106935.
    >> Share

  159. ARUMUGANAINAR D, Sekaran S
    Correspondence on "Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040".
    Oral Oncol. 2024;156:106933.
    >> Share

  160. GU LW, Zhang X, Zhang J, Xiao BB, et al
    The prognostic value of pretreatment (18)F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.
    Oral Oncol. 2024;156:106928.
    >> Share

  161. SURESH S
    Commentary on 'Mutation detection in saliva from oral cancer patients'.
    Oral Oncol. 2024;156:106937.
    >> Share

  162. KASIRAJAN H, Rengasamy G, Priya Veeraraghavan V
    Comment on the "Quality of life in 583 head and neck cancer survivors assessed with the FACE-Q head and neck cancer module".
    Oral Oncol. 2024;156:106934.
    >> Share

  163. KANNAN R
    Comments on: Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?
    Oral Oncol. 2024;156:106936.
    >> Share

  164. DAUNGSUPAWONG H, Wiwanitkit V
    Letter to the Editor on "Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance".
    Oral Oncol. 2024;156:106930.
    >> Share

  165. LIOKATIS P, Liokati I, Obermeier K, Smolka W, et al
    Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A systematic review.
    Oral Oncol. 2024;154:106808.
    >> Share

  166. PETERY T, Frankart AJ, Esslinger H, Wu X, et al
    The effect of treatment package time on locally advanced oral cavity cancer outcomes.
    Oral Oncol. 2024;154:106870.
    >> Share

  167. BEYAERT S, Borys A, Baldin P, Dahou H, et al
    Study of the PD-L1 expression, T-cells density and immunoscore in paired baseline tumor biopsies and surgical specimens in squamous cell carcinoma of the oral cavity.
    Oral Oncol. 2024;154:106869.
    >> Share

  168. SNEGA R, Saravanan M
    Comment on "Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC)".
    Oral Oncol. 2024;154:106851.
    >> Share

  169. DESILETS A, Pfister DG, Stein S, Wong W, et al
    A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer.
    Oral Oncol. 2024;154:106861.
    >> Share

  170. ADIBI A, Tokat UM, Ozgu E, Mamyrov N, et al
    Durable radiologic and molecular complete response following nivolumab in an HNSCC patient with UV signature and HIV.
    Oral Oncol. 2024;154:106859.
    >> Share

  171. SINGH M, Mishra N, Ray S, Bhusan Kar I, et al
    "Survival patterns and prognostic factors of gingivobuccal complex squamous cell cancer: A monocentric retrospective chart audit".
    Oral Oncol. 2024;154:106857.
    >> Share

  172. CHEN AM
    Translational risk-adapted approaches to de-escalated radiation for human papillomavirus-positive oropharyngeal cancer: Past, present, and future.
    Oral Oncol. 2024;154:106850.
    >> Share

  173. ZHI Y, Li S, Li Y, Ren W, et al
    Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study.
    Oral Oncol. 2024;154:106849.
    >> Share

  174. SATHISHKUMAR K
    Letter to the editor "risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial ".
    Oral Oncol. 2024;156:106931.
    >> Share

  175. HARIDEVAMUTHU B
    Letter to the Editor: "Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma".
    Oral Oncol. 2024;156:106913.
    >> Share

    June 2024
  176. BENJAMIN WJ, Feng AL, Heft Neal M, Bellile E, et al
    Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.
    Oral Oncol. 2024;156:106917.
    >> Share

  177. ZHAO X, Zhou Y, Peng G, Wen L, et al
    Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.
    Oral Oncol. 2024;156:106918.
    >> Share

  178. SARAVANAN M, Singh Carmelin D, Mohanprasanth A, Arockiaraj J, et al
    Comment on "Oral microbiome and risk of incident head and neck cancer: A nested case-control study".
    Oral Oncol. 2024;156:106911.
    >> Share

  179. POONGAVANAM SS, Behera A, Dharmalingam Jothinathan MK
    Letter to the editor, "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer".
    Oral Oncol. 2024;156:106912.
    >> Share

  180. JEYARAJ G
    Letter to the editor, "Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer".
    Oral Oncol. 2024;156:106906.
    >> Share

  181. DONG S, Bei W, Lin L, Jiang Y, et al
    Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.
    Oral Oncol. 2024;156:106908.
    >> Share

  182. JEYARAJ G
    Transformative impact of 3D-Printed implants and Virtual surgical planning in oral cancer reconstruction.
    Oral Oncol. 2024;156:106896.
    >> Share

  183. SHANMUGAM G
    Letter to the editor, "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.".
    Oral Oncol. 2024;156:106915.
    >> Share

  184. BASTIEN AJ, Ng J, Cong I, Garcia J, et al
    Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2024;156:106894.
    >> Share

  185. HARIDEVAMUTHU B
    Letter to the Editor: "Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral Cancer".
    Oral Oncol. 2024;155:106902.
    >> Share

  186. MEIVELU MOOVENDHAN
    Letter to the editor, "Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma".
    Oral Oncol. 2024;155:106903.
    >> Share

  187. PRASAD M, Sekar R, Murugan R
    Letter to editor on "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer".
    Oral Oncol. 2024;155:106899.
    >> Share

  188. SELVI POONGAVANAM S, Behera A, Kumar Dharmalingam Jothinathan M
    Letter to the Editor, "The predictive role of PD-L1 in head and neck Cancer: A systematic review and Meta-Analysis".
    Oral Oncol. 2024;155:106904.
    >> Share

  189. TOPKAN E, Somay E, Bascil S, Selek U, et al
    Comment on prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
    Oral Oncol. 2024;155:106898.
    >> Share

  190. HARIDEVAMUTHU B
    Genomic instability in HPV-positive oropharyngeal squamous cell carcinoma: The role of integration sites in treatment response.
    Oral Oncol. 2024;155:106895.
    >> Share

  191. LEI S, Chen L, Ji P, Li K, et al
    Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040.
    Oral Oncol. 2024;155:106891.
    >> Share

  192. DA MOTA SANTANA LA, Simoes JMD, Santos GA, Gopalsamy RG, et al
    Comment on "Association between COVID 19 exposure and expression of malignant pathological features in oral cancer: A retrospective cohort study".
    Oral Oncol. 2024;155:106877.
    >> Share

  193. ROOF SA, Jabalee J, Rettig EM, Chennareddy S, et al
    Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance.
    Oral Oncol. 2024;155:106874.
    >> Share

  194. FERRARI M, Mularoni F, Taboni S, Crosetti E, et al
    Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024) 106744].
    Oral Oncol. 2024 Jun 8:106887. doi: 10.1016/j.oraloncology.2024.106887.
    >> Share

  195. PRASAD M, Murugan R
    Comment on "The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-beta1/Smads/Snail1 axis".
    Oral Oncol. 2024;155:106890.
    >> Share

  196. TASOULAS J, Adams GJ, Schrank TP, Agala CB, et al
    Time to treatment for head and neck cancer patients decreased during the early phase of the Covid-19 pandemic.
    Oral Oncol. 2024;155:106879.
    >> Share

  197. DHARMALINGAM JOTHINATHAN MK
    Letter to the Editor, "How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? A multi-institutional study on 366 patients from the ARYFIX collaborative group".
    Oral Oncol. 2024;155:106878.
    >> Share

  198. DHARMALINGAM JOTHINATHAN MK
    Letter to the editor "Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019".
    Oral Oncol. 2024;153:106841.
    >> Share

  199. BISHESHAR SK, van der Kamp MF, de Vries J, Slagter-Menkema L, et al
    Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma.
    Oral Oncol. 2024;153:106830.
    >> Share

  200. WANG H, Hu L, Zhang F, Fang M, et al
    An investigative meta-analysis on the effectiveness and safety of integrating VEGF/VEGFR inhibitors with PD-1/PD-L1 inhibitors in cases with R/M HNSCC.
    Oral Oncol. 2024;153:106814.
    >> Share

  201. BABU S, Krishnan M
    Human papillomavirus and oropharyngeal cancer in HNSCC: A growing concern.
    Oral Oncol. 2024;153:106824.
    >> Share

  202. ADRIAANSENS CMEM, de Koning KJ, van Es RJJ, de Bree R, et al
    Beneath the surface: A systematic review on intraoperative imaging techniques for deep margin assessment in oral squamous cell carcinoma.
    Oral Oncol. 2024;153:106823.
    >> Share

  203. SARAVANAN M
    Comment on "Prognostic biomarkers in oral squamous cell carcinoma: A systematic review".
    Oral Oncol. 2024;153:106805.
    >> Share

  204. PACE GM, Costantino A, Festa BM, Spriano G, et al
    Oropharyngeal squamous cell carcinoma: Treatment (de-) intensification?
    Oral Oncol. 2024;153:106299.
    >> Share

  205. SHAHA AR
    Completion thyroidectomy for intermediate risk factors after thyroid lobectomy.
    Oral Oncol. 2024;153:106240.
    >> Share

  206. KRC R, Mendes W, Molitoris J, Ferris M, et al
    Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer.
    Oral Oncol. 2024;154:106875.
    >> Share

  207. LU HA, Wang YM, Chih Chen W, Wu CN, et al
    Post-irradiation dysbiosis in patients with nasopharyngeal carcinoma having received radiotherapy - A pilot study.
    Oral Oncol. 2024;154:106864.
    >> Share

    May 2024
  208. XU W, Qiu L, Li F, Fei Y, et al
    Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
    Oral Oncol. 2024;154:106865.
    >> Share

  209. IMAMURA Y, Kiyota N, Tahara M, Kodaira T, et al
    Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.
    Oral Oncol. 2024;154:106868.
    >> Share

  210. PARK R, Li J, Slebos RJC, Chaudhary R, et al
    Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2024;154:106866.
    >> Share

  211. SARAVANAN M, Carmelin DS, Mohanprasanth A, Arockiaraj J, et al
    Comment on "Oral microbiome and risk of incident head and neck cancer: A nested case-control study".
    Oral Oncol. 2024;154:106858.
    >> Share

  212. HESHAM A, David Kim D, Alshamrani Y, AlOtaibi F, et al
    The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in recurrent head and neck squamous cell carcinoma. Report of a case and review of the literature.
    Oral Oncol. 2024;154:106863.
    >> Share

  213. ABBACI M, Villard A, Auperin A, Asmandar S, et al
    Ultra-fast confocal fluorescence microscopy for neck lymph node imaging in head and neck cancer.
    Oral Oncol. 2024;154:106862.
    >> Share

  214. YAO Y, Ouyang Q, Wang S, Li K, et al
    Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort.
    Oral Oncol. 2024;154:106867.
    >> Share

  215. RICARDO ELIAS DE MELO P, Agra Monteiro M, Vitoria de Araujo Lopes N, Silva Cunha JL, et al
    In response to the reply on 'Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with teledentistry for enhanced patient outcomes'.
    Oral Oncol. 2024;154:106856.
    >> Share

  216. COSTANTINO A, Haughey B, Zhu J, Mekhail T, et al
    Sinonasal squamous cell carcinoma in the United States: Temporal and geographic patterns associated with HPV testing and positivity.
    Oral Oncol. 2024;154:106855.
    >> Share

  217. PEZZULLA D, Re A, Ferro M, Cilla S, et al
    Lower cranial nerve palsy after hypofractionated radiotherapy in a laryngeal cancer patient: A letter to the editor.
    Oral Oncol. 2024;154:106837.
    >> Share

  218. ALVES DA MOTA SANTANA L, Gois Floresta L, Maciel Alves EV, Ribeiro Couto G, et al
    Reply to: Comment on "Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with teledentistry for enhanced patient outcomes".
    Oral Oncol. 2024;154:106840.
    >> Share

  219. HE S, Yu H, He L, Liu M, et al
    Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors.
    Oral Oncol. 2024;154:106827.
    >> Share

  220. VAZQUEZ FL, Coracin FL, Arantes KLBF, Ferigatto JL, et al
    An oral cancer screening program in Brazil: Analysis of seven years of outcome after its implementation in the suburban cities of Sao Paulo.
    Oral Oncol. 2024;154:106826.
    >> Share

  221. DE FELICE F, Guerrero Urbano T
    Lower-neck sparing in patients with uninvolved neck nasopharyngeal carcinoma: Unquestioned benefit?
    Oral Oncol. 2024;154:106836.
    >> Share

  222. HAN N, Zhou D, Ruan M, Yan M, et al
    Corrigendum to "Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer" [Oral Oncol. 145 (2023) 106524].
    Oral Oncol. 2024 May 9:106831. doi: 10.1016/j.oraloncology.2024.106831.
    >> Share

  223. INVERNIZZI C, Da Silva Ribeiro Mota A, Barbe C, Bouazzi L, et al
    Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
    Oral Oncol. 2024;153:106833.
    >> Share

  224. PADERNO A, Petrelli F, Lorini L, Capriotti V, et al
    The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis.
    Oral Oncol. 2024;153:106799.
    >> Share

  225. LIU Y, Zuo ZC, Zeng XY, Ma J, et al
    Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study.
    Oral Oncol. 2024;153:106834.
    >> Share

  226. XU Y, Xu T, Yao Q, Chen J, et al
    Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma.
    Oral Oncol. 2024;153:106828.
    >> Share

  227. ALMANGUSH A, Makitie AA, Leivo I
    Assessment of tumor-infiltrating lymphocytes in head and neck cancer: Clinical scenarios.
    Oral Oncol. 2024;153:106829.
    >> Share

  228. DAS R, Misra SR
    Author's reply to comment on "awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?".
    Oral Oncol. 2024;153:106832.
    >> Share

  229. SEKAR D
    Comment on BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients.
    Oral Oncol. 2024;152:106812.
    >> Share

  230. DHARMALINGAM JOTHINATHAN MK
    Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Oral Oncol. 2024;152:106811.
    >> Share

  231. FEARINGTON FW, Zhao CY, Romero-Brufau S, Moore EJ, et al
    Addressing positive multi-cancer early detection tests in head and neck Surgery: Experience with head and neck work up for high-risk referrals.
    Oral Oncol. 2024;152:106809.
    >> Share

  232. LENG X, Sun X, Lin Y, Zhang C, et al
    Secretory carcinoma in the parotid gland presenting as a cystic lesion and harboring ETV6?NTRK3 gene rearrangement.
    Oral Oncol. 2024;152:106804.
    >> Share

  233. ZHANG R, Wong LM, So TY, Cai Z, et al
    Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI.
    Oral Oncol. 2024;152:106796.
    >> Share

  234. ICHIMURA N, Urata Y, Kobayashi T, Hibi H, et al
    Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
    Oral Oncol. 2024;152:106807.
    >> Share

  235. PERUMAL MKK, Renuka RR, Srinivasan GP, Jothinathan MKD, et al
    Cancer stem cells biomarkers and the dynamics of the tumor microenvironment in oral squamous cell carcinoma.
    Oral Oncol. 2024;152:106797.
    >> Share

  236. SARAVANAN M
    Comment on "Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: Correlation with clinicopathological features".
    Oral Oncol. 2024;152:106791.
    >> Share

  237. POOJARI M, Madabhavi I, Desai S
    Extraskeletal Ewing's sarcoma of supraglottis: A rare case report.
    Oral Oncol. 2024;152:106789.
    >> Share

  238. XU R
    Comment on: Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
    Oral Oncol. 2024;152:106767.
    >> Share

  239. MELDGAARD JUSTESEN M, Kronberg Jakobsen K, Fenger Carlander AL, Hjordt Holm Larsen M, et al
    Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Oral Oncol. 2024;152:106783.
    >> Share

  240. DE MELO CARDOSO D, Conrado Neto S, Urbano Collado F, Furuse C, et al
    Tongue cancer in non-smoking and non-alcoholic mother and daughter.
    Oral Oncol. 2024;152:106779.
    >> Share

  241. AKHTAR A, Akhtar R
    Response to " impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019''.
    Oral Oncol. 2024;152:106777.
    >> Share

  242. ZHAO H, Liu CH, Lu Y, Liu SZ, et al
    BRAF(V600E) mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients.
    Oral Oncol. 2024;152:106755.
    >> Share

  243. SMITH JD, Sridharan SS, Contrera KJ, Richmon JD, et al
    Use of the spider limb positioner for fibular free flap reconstruction of head and neck bony defects.
    Oral Oncol. 2024;152:106757.
    >> Share

    April 2024
  244. TONSBEEK AM, Hundepool CA, Roubos J, Rijken B, et al
    Quality of life in 583 head and neck cancer survivors assessed with the FACE-Q head and neck cancer module.
    Oral Oncol. 2024;153:106813.
    >> Share

  245. MICHIKAWA C, Gleber-Netto FO, Pickering CR, Rao X, et al
    Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer.
    Oral Oncol. 2024;153:106729.
    >> Share

  246. FANG Q, Yuan J, Zhang X, Dai L, et al
    Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
    Oral Oncol. 2024;152:106810.
    >> Share

  247. YEO BSY, Lee RS, Lim NE, Tan E, et al
    Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma - A Systematic Review and Meta-analysis.
    Oral Oncol. 2024;152:106786.
    >> Share

  248. LI Y, Zhou Y, Zhao C, Liu L, et al
    The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-beta1/Smads/Snail1 axis.
    Oral Oncol. 2024;152:106798.
    >> Share

  249. RAMASAMY P, Sekaran S, Ganapathy D
    Oral cancer burden in tribal populations residing in India.
    Oral Oncol. 2024;152:106801.
    >> Share

  250. SEKAR D
    Comment on betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study.
    Oral Oncol. 2024;152:106800.
    >> Share

  251. SARAVANAN M
    Comment on "Nanomedicine, an emerging therapeutic strategy for oral cancer therapy".
    Oral Oncol. 2024;152:106806.
    >> Share

  252. RICARDO ELIAS DE MELO P, Agra Monteiro M, Henrique Rocha Aragao H, Vitoria de Araujo Lopes N, et al
    Comment on "Awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?".
    Oral Oncol. 2024;152:106802.
    >> Share

  253. SMITH JD, Heft-Neal ME, Rosko AJ, Chepeha DB, et al
    Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma.
    Oral Oncol. 2024;152:106803.
    >> Share

  254. KONO M, Saito S, Rokugo M, Egloff AM, et al
    Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer.
    Oral Oncol. 2024;152:106795.
    >> Share

  255. SEGNA E, Civita F, Denaro N, Beltramini GA, et al
    Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer.
    Oral Oncol. 2024;152:106784.
    >> Share

  256. SIVAPERUMAL P, Ganapathy D, Kamala K
    Revolutionizing oral cancer treatment: Harnessing the potential of adaptive CARneg T cell therapy.
    Oral Oncol. 2024;152:106794.
    >> Share

  257. RAJAKUMAR HK, Coimbatore Sathyabal V, Vivekanandam A, Nasrin Jabarulla K, et al
    Evaluation of nuclear morphometry in exfoliative cytology of buccal mucosa in patients with high risk of oral cancer.
    Oral Oncol. 2024;152:106793.
    >> Share

  258. SARAVANAN M
    Comment on "The microbiome and oral cancer: More questions than answers".
    Oral Oncol. 2024;152:106792.
    >> Share

  259. ARAGAO HHR, Monteiro MA, Lopes NVA, Cunha JLS, et al
    Comment on "Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study".
    Oral Oncol. 2024;152:106788.
    >> Share

  260. DAS R, Misra SR, Nayak A
    Awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?
    Oral Oncol. 2024;152:106790.
    >> Share

  261. XIAO X, Shi Z, Song Z
    Comment on circulatory mitochondrial DNA as a novel biomarker for head and neck cancers.
    Oral Oncol. 2024;152:106785.
    >> Share

  262. GASNE C, Atallah S, Dauzier E, Thariat J, et al
    Twelve years after: The french national network on rare head and neck tumours (REFCOR).
    Oral Oncol. 2024;151:106762.
    >> Share

  263. MAUCERI R, Coppini M, Perez-Sayans M, Toro C, et al
    Challenges in the diagnosis of oral squamous cell carcinoma mimicking medication-related osteonecrosis of the jaws: a multi-hospital-based case series.
    Oral Oncol. 2024;151:106689.
    >> Share

  264. HUANG J, Fehr A, Jawert F, Nilsson JA, et al
    MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
    Oral Oncol. 2024;151:106763.
    >> Share

  265. MIGLIARI D
    Does a biopsy improve the diagnosis of oral lichen planus and management of the patient? In which scenario does the malignant transformation matter most?
    Oral Oncol. 2024;151:106764.
    >> Share

  266. HUA Y, Ma P, Li C, Gao N, et al
    Association between COVID 19 exposure and expression of malignant pathological features in oral squamous cell carcinoma: A retrospective cohort study.
    Oral Oncol. 2024;151:106740.
    >> Share

  267. MORIWAKI K, Ayani Y, Kuwabara H, Terada T, et al
    Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness.
    Oral Oncol. 2024;151:106751.
    >> Share

  268. MALI SB
    Role of telemedicine in head neck cancer.
    Oral Oncol. 2024;151:106746.
    >> Share

  269. KANG CJ, Lee LY, Ng SH, Lin CY, et al
    Should sub-millimeter margins be deemed positive in oral cavity squamous cell carcinoma?
    Oral Oncol. 2024;151:106745.
    >> Share

  270. MIRIMOGHADDAM M, Bohlouli B, Lai H, Viegas S, et al
    Trends and predictors of unplanned hospitalization among oral and oropharyngeal cancer patients; an 8-year population-based study.
    Oral Oncol. 2024;151:106742.
    >> Share

  271. FARAH CS, Shearston K, Turner EC, Vacher M, et al
    Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
    Oral Oncol. 2024;151:106737.
    >> Share

  272. HUNG CY, Lee TL, Chang CW, Wang CP, et al
    Margin to depth of invasion ratio as an indicator for stratifying close margins in early-stage oral squamous cell carcinoma.
    Oral Oncol. 2024;151:106726.
    >> Share

    March 2024
  273. MEGAHED R, Prabhu AV, Mack DP, Gholami S, et al
    Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
    Oral Oncol. 2024;152:106778.
    >> Share

  274. LORINI L, Gili R, Salvestrini V, Morelli I, et al
    De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control "always" matter?
    Oral Oncol. 2024;152:106768.
    >> Share

  275. XIROU V, Moutafi M, Bai Y, Nwe Aung T, et al
    An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
    Oral Oncol. 2024;152:106750.
    >> Share

  276. HONG RL, Yen CJ, Lien MY, Cheng R, et al
    Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study.
    Oral Oncol. 2024;152:106760.
    >> Share

  277. FERRARI M, Mularoni F, Taboni S, Crosetti E, et al
    How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group.
    Oral Oncol. 2024;152:106744.
    >> Share

  278. TOYA R, Fukugawa Y, Saito T, Matsuyama T, et al
    Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
    Oral Oncol. 2024;151:106752.
    >> Share

  279. RUIZ-TORRES DA, Naegele S, Podury A, Wirth L, et al
    Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis.
    Oral Oncol. 2024;151:106761.
    >> Share

  280. SIMON L, Paly J, Park E, Samuels-Kalow M, et al
    Medicare dental coverage for patients with head and neck cancer: An opportunity in need of advocates.
    Oral Oncol. 2024 Mar 15:106754. doi: 10.1016/j.oraloncology.2024.106754.
    >> Share

  281. RICARDO ELIAS DE MELO P, Agra Monteiro M, Vitoria de Araujo Lopes N, Silva Cunha JL, et al
    Comment on "advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with Teledentistry for Better Patient Outcomes".
    Oral Oncol. 2024;151:106758.
    >> Share

  282. RAJANATHADURAI J, Sindya J, Madar IH, Perumal E, et al
    Exosomal immune checkpoint protein (PD-L1): Hidden player in PD-1/PD-L1 blockade immunotherapy resistance in oral cancer.
    Oral Oncol. 2024;151:106748.
    >> Share

  283. ZUPANCIC M, Kostopoulou ON, Holzhauser S, Lukoseviciute M, et al
    Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
    Oral Oncol. 2024;151:106749.
    >> Share

  284. FERRARO T, Pershad AR, Arora S, Lee E, et al
    The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer.
    Oral Oncol. 2024;151:106743.
    >> Share

  285. KIM DH, Lim ST, Kim HR, Kang EJ, et al
    Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study.
    Oral Oncol. 2024;151:106739.
    >> Share

  286. SANTANA LADM, Floresta LG, Alves EVM, Melo LMR, et al
    Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence with teledentistry for enhanced patient outcomes.
    Oral Oncol. 2024;151:106741.
    >> Share

  287. CHEN K, Shi M, Mo S, Liu T, et al
    Clinical features and prognostic factors of nasopharyngeal carcinoma with brain metastases.
    Oral Oncol. 2024;151:106738.
    >> Share

  288. DING C, Dai DY, Luo ZK, Wang GY, et al
    Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
    Oral Oncol. 2024;151:106725.
    >> Share

  289. DOU CB, Fu YH, Yu ZL, Jia J, et al
    Proliferative verrucous leukoplakia: Report of a case and literature review.
    Oral Oncol. 2024;150:106720.
    >> Share

  290. AKHTAR A, Akhtar R, Zaidi E
    Response to "lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid".
    Oral Oncol. 2024;150:106718.
    >> Share

  291. SMITH JD, Sridharan SS, Contrera KJ, Brown SA, et al
    Hyoid osteoradionecrosis as an acute sequelae of irradiation for base of tongue tumors: A complication on the rise?
    Oral Oncol. 2024;150:106696.
    >> Share

  292. LU X, Zhang JL, Zhai X, Liu Q, et al
    A case report on a nasal and oral cavity involving large solitary fibrous tumor and comprehensive review of case literature.
    Oral Oncol. 2024;150:106715.
    >> Share

  293. DA MOTA SANTANA LA, Goncalo RIC, Floresta LG, de Oliveira EM, et al
    Integrating ChatGPT in oral cytopathology: Enhancing fine needle aspiration diagnostic accuracy for malignant lesions.
    Oral Oncol. 2024;150:106685.
    >> Share

  294. COSTANTINO A, Sampieri C, Meliante PG, De Virgilio A, et al
    Reply to: Comment on "Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems".
    Oral Oncol. 2024;150:106700.
    >> Share

  295. SILVA MELO T, Isabelly Rodrigues-Fernandes C, Melo de Lima Morais T, Paes de Almeida O, et al
    Primary intestinal-type adenocarcinoma: Report of a rare case involving a young patient.
    Oral Oncol. 2024;150:106697.
    >> Share

  296. CHOU CW, Lan MY, Kuo YJ, Yeh CF, et al
    Perineural invasion is a poor prognostic factor for sinonasal squamous cell carcinoma.
    Oral Oncol. 2024;150:106698.
    >> Share

  297. GAO Y, Tang Y, Zhang X, Wu P, et al
    A rare case of thyroid carcinosarcoma arising from recurrent papillary thyroid cancer: Case report and review of the literature.
    Oral Oncol. 2024;150:106694.
    >> Share

  298. YOUNG RJ, Angel C, Bressel M, Pizzolla A, et al
    Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer.
    Oral Oncol. 2024;150:106687.
    >> Share

    February 2024
  299. VAN SCHAIK JE, van der Vegt B, Slagter-Menkema L, van der Laan BFAM, et al
    Identification of new head and neck squamous cell carcinoma molecular imaging targets.
    Oral Oncol. 2024;151:106736.
    >> Share

  300. MELACHURI M, Kurukulasuriya C, Rumde P, Patel T, et al
    Treatment package time < 14 weeks improves recurrence free and disease specific survival in HPV positive OPC with high-risk features.
    Oral Oncol. 2024;151:106703.
    >> Share

  301. AHMED AA, Sborchia M, Bye H, Roman-Escorza M, et al
    Mutation detection in saliva from oral cancer patients.
    Oral Oncol. 2024;151:106717.
    >> Share

  302. CHEN QY, Guo SS, Luo Y, Qu S, et al
    Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
    Oral Oncol. 2024;151:106723.
    >> Share

  303. FANCELLO G, Jiang S, Licci G, Gallo O, et al
    Comments on the article titled "Factors associated with unknown primary status in head and neck squamous cell carcinoma": Is the N status the overlooked elephant in the room?
    Oral Oncol. 2024;151:106727.
    >> Share

  304. HU J, Huang Q, Hu W, Liang F, et al
    Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
    Oral Oncol. 2024;151:106683.
    >> Share

  305. CABEZAS-CAMARERO S, Vazquez Masedo G, Puebla-Diaz F, Corona JA, et al
    Major and durable responses to photon and electron-beam palliative radiotherapies after immune-checkpoint inhibitors in head and neck cancer.
    Oral Oncol. 2024;150:106719.
    >> Share

  306. SANTANA NCM, de Sena ACVP, Rocha PADS, de Arruda JAA, et al
    Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia - A systematic review.
    Oral Oncol. 2024;150:106699.
    >> Share

  307. BATTISTI A, Della Monaca M, Di Giorgio D, Priore P, et al
    Extranodal follicular dendritic cell sarcoma of the tonsil: An extremely rare clinical entity.
    Oral Oncol. 2024;149:106690.
    >> Share

  308. LE MEITOUR Y, Foy JP, Guinand M, Michon L, et al
    Uncovering immune checkpoint heterogeneity in oral squamous cell carcinoma using single cell RNA-sequencing data highlights three subgroups of patients with distinct immune phenotypes.
    Oral Oncol. 2024;149:106680.
    >> Share

  309. ADEN AA, Olawuni FO, Abdel-Halim CN, Zhu AQ, et al
    Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer.
    Oral Oncol. 2024;149:106675.
    >> Share

  310. JUSTESEN MM, Stampe H, Jakobsen KK, Andersen AO, et al
    Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019.
    Oral Oncol. 2024;149:106684.
    >> Share

  311. KIM D, Choi K, Park H, Song J, et al
    Genetic characteristics of a highly metastatic basal cell adenocarcinoma arising in buccal mucosa.
    Oral Oncol. 2024;149:106681.
    >> Share

  312. HEIRMAN AN, Dirven R, van der Molen L, Schreuder WH, et al
    The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands - A mixed methods study.
    Oral Oncol. 2024;149:106677.
    >> Share

  313. MEIRELLES DP, Da Costa AAS, Sousa-Neto SS, Cardoso SV, et al
    Methodological challenges in identifying histological prognostic markers for squamous cell carcinoma of the lip, mouth, and oropharynx.
    Oral Oncol. 2024;149:106665.
    >> Share

  314. CHEN L, Lin J, Wen Y, Lan B, et al
    A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC.
    Oral Oncol. 2024;149:106659.
    >> Share

  315. BALASAMY S, Sundramoorthy AK
    EGFR-targeted fluorescence imaging for precision margin assessment in oral cancer surgery.
    Oral Oncol. 2024;150:106712.
    >> Share

    January 2024
  316. OCHOA SCUSSIATTO H, Stenson KM, Al-Khudari S, Jelinek MJ, et al
    Air pollution is associated with increased incidence-rate of head and neck cancers: A nationally representative ecological study.
    Oral Oncol. 2024;150:106691.
    >> Share

  317. LI L, Chen L, Fan M, Tian Y, et al
    A prospective, single-arm trial of PD-1 inhibitors plus chemoradiotherapy for solitary metachronous metastasis nasopharyngeal carcinoma.
    Oral Oncol. 2024;150:106695.
    >> Share

  318. STOGBAUER F, Otto R, Johrens K, Tinhofer I, et al
    Molecular subtyping of head and neck cancer - Clinical applicability and correlations with morphological characteristics.
    Oral Oncol. 2024;149:106678.
    >> Share

  319. JAGADEESHAN S, Suryamohan K, Shin N, Mathukkada S, et al
    Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma.
    Oral Oncol. 2024;149:106688.
    >> Share

  320. PUJOL A, Leon X, Holgado A, Valero C, et al
    External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy.
    Oral Oncol. 2024;149:106686.
    >> Share

  321. DE ARAUJO LOPES NV, Alves PM, Silva Cunha JL
    Comment on "Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems".
    Oral Oncol. 2024;148:106653.
    >> Share

  322. TOPKAN E, Somay E, Selek U
    Comment on "Predictors of prolonged treatment time intervals in oral cavity cancer".
    Oral Oncol. 2024;148:106652.
    >> Share

  323. FILIPPINI DM, Pagani R, Tober N, Lorini L, et al
    HER2-targeted therapies for salivary gland cancers.
    Oral Oncol. 2024;148:106612.
    >> Share

  324. SHENKER RF, Razavian NB, D'Agostino RB Jr, Mowery YM, et al
    Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
    Oral Oncol. 2024;148:106644.
    >> Share

  325. ZHANG SL, Ma SR, Mao L, Yu ZL, et al
    One case of sublingual gland mucosa-associated lymphoid tissue lymphoma.
    Oral Oncol. 2024;148:106648.
    >> Share

  326. COSTANTINO A, Sampieri C, Pace GM, Festa BM, et al
    Development of machine learning models for the prediction of long-term feeding tube dependence after oral and oropharyngeal cancer surgery.
    Oral Oncol. 2024;148:106643.
    >> Share

  327. NORONHA V, Dhanawat A, Patil VM, Menon N, et al
    Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice.
    Oral Oncol. 2024;148:106633.
    >> Share

  328. CAPONE E, Perrotti V, Cela I, Lattanzio R, et al
    Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma.
    Oral Oncol. 2024;148:106635.
    >> Share

  329. MONTEIRO MA, de Araujo Lopes NV, de Carvalho Chaves-Junior S, Weegee Nonaka CF, et al
    A rare case of oral squamous cell carcinoma in a patient with Cowden syndrome: Association or coincidence?
    Oral Oncol. 2024;148:106630.
    >> Share

  330. SARODE GS, Sarode SC
    Comment on "Predictors of prolonged treatment time intervals in oral cavity cancer".
    Oral Oncol. 2024;148:106631.
    >> Share

  331. COSTANTINO A, Sampieri C, Meliante PG, De Virgilio A, et al
    Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems.
    Oral Oncol. 2024;148:106629.
    >> Share

    December 2023
  332. TOPKAN E, Somay E, Selek U
    Comment on "A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer".
    Oral Oncol. 2023;149:106679.
    >> Share

  333. AKHTAR A, Akhtar R, Nasir BM
    Response to "Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma".
    Oral Oncol. 2023;149:106674.
    >> Share

  334. SICHERO L, Goncalves MG, Bettoni F, Coser EM, et al
    Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil.
    Oral Oncol. 2023;149:106676.
    >> Share

  335. BILA M, Franken A, Van Dessel J, Garip M, et al
    Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2023;149:106664.
    >> Share

  336. GUO Y, Nakashima T, Cho BC, Lim DW, et al
    Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific.
    Oral Oncol. 2023;148:106657.
    >> Share

  337. HUANG H, Chen Z, Zhu M, Deng X, et al
    Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials.
    Oral Oncol. 2023;148:106656.
    >> Share

  338. CHEN W, Yu X, Li H, Yuan S, et al
    Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
    Oral Oncol. 2023;148:106654.
    >> Share

  339. NEO J, Yip PL, Ong EHW, Miao J, et al
    Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma.
    Oral Oncol. 2023;148:106655.
    >> Share

  340. CUNHA JLS
    Comment on "Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers".
    Oral Oncol. 2023;147:106628.
    >> Share

  341. WILLIAMSON A, Moen CM, Slim MAM, Warner L, et al
    Transoral robotic surgery without adjuvant therapy: A systematic review and meta-analysis of the association between surgical margins and local recurrence.
    Oral Oncol. 2023;147:106610.
    >> Share

  342. SILVA CUNHA JL
    Comment on "Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer".
    Oral Oncol. 2023;147:106626.
    >> Share

  343. TIRELLI G, Boscolo-Rizzo P
    Palatoglossus muscle involvement in oropharynx Carcinoma: A pitfall in the T4 category definition of the 8th edition of the TNM staging system?
    Oral Oncol. 2023;147:106627.
    >> Share

  344. FARLOW JL, McCrary HC, Sipos JA, Phay JE, et al
    Neoadjuvant dabrafenib and trametinib for functional organ preservation in recurrent BRAF V600E-mutated papillary thyroid cancer.
    Oral Oncol. 2023;147:106625.
    >> Share

  345. WEIJERS JAM, de Bitter TJJ, Verhaegh GW, van Boxtel W, et al
    Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.
    Oral Oncol. 2023;147:106620.
    >> Share

  346. DOS SANTOS CMB, Cunha JLS, Barnabe LEG, Nonaka CFW, et al
    Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor.
    Oral Oncol. 2023;147:106617.
    >> Share

  347. BARROS EF, Cunha JLS, de Sousa DP, Pereira RVS, et al
    A destructive sinonasal organizing hematoma mimicking malignancy.
    Oral Oncol. 2023;147:106619.
    >> Share

  348. CAO LM, Zhong NN, Liu B, Sun YF, et al
    A surge of hope: A case of lymph node hyperplasia after oral squamous cell carcinoma neoadjuvant immunotherapy.
    Oral Oncol. 2023;147:106613.
    >> Share

  349. CORTINA LE, Meyer CD, Feng AL, Lin DT, et al
    Depth of resection predicts loss of tongue tip sensation after partial glossectomy in oral tongue cancer: A pilot study.
    Oral Oncol. 2023;147:106595.
    >> Share

  350. LENG X, Zou L, Huang H, Wang Y, et al
    Protrusion deviation due to intramuscular granular cell tumor of the tongue.
    Oral Oncol. 2023;147:106581.
    >> Share

  351. DEWENTER I, Kumbrink J, Poxleitner P, Smolka W, et al
    New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma.
    Oral Oncol. 2023;147:106573.
    >> Share

  352. DAYAN G, Bahig H, Fortin B, Filion E, et al
    Predictors of prolonged treatment time intervals in oral cavity cancer.
    Oral Oncol. 2023;147:106622.
    >> Share

  353. SPENCE RN, Efthymiou V, Goss D, Varvares MA, et al
    Margin distance in oral tongue cancer surgery: A systematic review of survival and recurrence outcomes.
    Oral Oncol. 2023;147:106609.
    >> Share

  354. RAMADAN S, Lee JJ, Wang R, Jackson RS, et al
    Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers.
    Oral Oncol. 2023;147:106607.
    >> Share

  355. GRAVES JP, Daher GS, Bauman MMJ, Moore EJ, et al
    Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis.
    Oral Oncol. 2023;147:106608.
    >> Share

  356. CHENG JY, Hsu RC, Nieva JJ, Thomas JS, et al
    Complete response with pembrolizumab in recurrent squamous cell carcinoma of the oral tongue: A case report.
    Oral Oncol. 2023;147:106597.
    >> Share

  357. CORTINA LE, Moverman DJ, Zhao Y, Goss D, et al
    Functional considerations between flap and non-flap reconstruction in oral tongue cancer: A systematic review.
    Oral Oncol. 2023;147:106596.
    >> Share

    November 2023
  358. KALAVACHERLA S, Li V, Voora R, Victor M, et al
    Factors associated with unknown primary status in head and neck squamous cell carcinoma.
    Oral Oncol. 2023;148:106650.
    >> Share

  359. ZHANG S, Zheng M, Tian H, Liu W, et al
    Are immune checkpoint inhibitors ineffective in treating patients with head and neck squamous cell carcinoma aged 75 years or Older? A Meta-Analysis.
    Oral Oncol. 2023;148:106632.
    >> Share

  360. CHIU KW, Yu TP, Kao YS
    A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer.
    Oral Oncol. 2023;148:106649.
    >> Share

  361. DE SENA ACVP, de Arruda JAA, Felix FA, Tavares TS, et al
    Oral carcinoma in situ in a middle-aged woman with systemic sclerosis: Report of a rare case and literature review.
    Oral Oncol. 2023;148:106646.
    >> Share

  362. HES C, Desilets A, Tonneau M, El Ouarzadi O, et al
    Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2023;148:106623.
    >> Share

  363. GAFFNEY J, Ramzan A, Dinizulu T, Maley C, et al
    Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer.
    Oral Oncol. 2023;148:106645.
    >> Share

  364. CHEN AM, Harris JP, Tjoa T, Haidar Y, et al
    Racial disparities in the timely receipt of adjuvant radiotherapy for head and neck cancer.
    Oral Oncol. 2023;147:106611.
    >> Share

  365. TAKESHITA N, Enokida T, Okano S, Fujisawa T, et al
    Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
    Oral Oncol. 2023;147:106615.
    >> Share

  366. YU SM, Hsu CC, Hsueh SW, Hung CY, et al
    Frailty assessment by two screening instruments in non-elderly patients with head and neck cancer.
    Oral Oncol. 2023;147:106621.
    >> Share

  367. HARRINGTON KJ, Cohen EEW, Soulieres D, Dinis J, et al
    Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.
    Oral Oncol. 2023;147:106587.
    >> Share

  368. CHEN J, Shen X, Lian M, Fang J, et al
    Parapharyngeal space ectopic thyroid with eutopic papillary thyroid cancer: A case report.
    Oral Oncol. 2023;146:106577.
    >> Share

  369. MOSS WJ, Kwon D, Wu N, Brett P, et al
    Complete clinicoradiographic remission following immunotherapy treatment for an unresectable, multiply-recurrent oral verrucous carcinoma: A letter to the editor.
    Oral Oncol. 2023;146:106567.
    >> Share

  370. KAUL P, Garg PK
    Oral metronomic therapy as a resource-adaptive palliative strategy for recurrent/metastatic head and neck squamous cell cancers.
    Oral Oncol. 2023;146:106576.
    >> Share

  371. DERMODY SM, McMichael BM, Bellile E, Marchiano EJ, et al
    Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma.
    Oral Oncol. 2023;146:106572.
    >> Share

  372. ABDEL-HALIM CN, O'Byrne TJ, Graves JP, Akpala CO, et al
    Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.
    Oral Oncol. 2023;146:106569.
    >> Share

  373. BARTEMES KR, Gochanour BR, Routman DM, Ma DJ, et al
    Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Oral Oncol. 2023;146:106568.
    >> Share

  374. HEI H, Luo Z, Zheng C, Gong W, et al
    Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
    Oral Oncol. 2023;146:106563.
    >> Share

  375. WU S, Qi J, Abudunaibi M, Xu H, et al
    Letter to the Editor regarding, "Gland-preserving surgery of benign parotid tumors via postauricular sulcus incision: Is it safe and effective with the scarless incision?".
    Oral Oncol. 2023;146:106559.
    >> Share

  376. YU W, Ding C, Li K
    Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.
    Oral Oncol. 2023;146:106541.
    >> Share

  377. KWON JJY, Liu AQ, Milner TD, Prisman E, et al
    Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer.
    Oral Oncol. 2023;146:106537.
    >> Share

  378. HERMSEN MA, Lechner M, Oliveira Ferrer L, Trama A, et al
    EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.
    Oral Oncol. 2023;146:106543.
    >> Share

  379. SARAVANAN M, Arockiaraj J
    Relationship between GLUT-1 and HIF-1alpha: Is it a friend or foe for studying the biological behaviour of head-and-neck tumorigenesis?
    Oral Oncol. 2023;146:106553.
    >> Share

  380. SARODE GS, Sarode SC, Sharma N
    Comment on "Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening".
    Oral Oncol. 2023;147:106614.
    >> Share

    October 2023
  381. ANSARI E, Ganry L, Van Cann EM, de Bree R, et al
    Impact of low skeletal muscle mass on postoperative complications in head and neck cancer patients undergoing free flap reconstructive surgery - A systematic review and meta-analysis.
    Oral Oncol. 2023;147:106598.
    >> Share

  382. LIU ZQ, Zhao YN, Wu YS, Zhang BY, et al
    Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma.
    Oral Oncol. 2023;147:106583.
    >> Share

  383. BATOOL S, Sethi RKV, Wang A, Dabekaussen K, et al
    Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
    Oral Oncol. 2023;147:106584.
    >> Share

  384. ROBERTI E, Merlano M, Ravanelli M, Alberti A, et al
    Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
    Oral Oncol. 2023;145:106540.
    >> Share

  385. MYOKEN Y, Kawamoto T, Fujita Y, Toratani S, et al
    Oral squamous cell carcinoma clinico-radiographically mimicking MRONJ.
    Oral Oncol. 2023;145:106498.
    >> Share

  386. REVERDY T, Varnier R, de Talhouet S, Duplomb S, et al
    Analysis of the benefit of salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck.
    Oral Oncol. 2023;145:106533.
    >> Share

  387. KEMNADE JO, Florez M, Sabichi A, Zhang J, et al
    Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
    Oral Oncol. 2023;145:106536.
    >> Share

  388. KALMEGH P, Sonone A, Hande A, Gawande M, et al
    Epithelial-myoepithelial carcinoma with multiple recurrences: An unusual presentation.
    Oral Oncol. 2023;145:106538.
    >> Share

  389. JANG HB, Lee DH, Jung EK, Lee JK, et al
    Diagnostic tips for parotid lymphoma.
    Oral Oncol. 2023;145:106525.
    >> Share

  390. OH KY, Hong SD
    Infarction of basal cell adenoma of the parotid gland: First case report and literature review on CTNNB1 I35T mutations in salivary basal cell neoplasms.
    Oral Oncol. 2023;145:106534.
    >> Share

  391. SARAVANAN M, Sampath S, Arockiaraj J
    The use of advanced transoral robotic surgery in the treatment of oropharynx squamous cell carcinoma: A modern alternative for open surgery.
    Oral Oncol. 2023;145:106522.
    >> Share

  392. MISRA SR, Das R, Karthikeyan R
    Quality of life in patients with oral squamous cell carcinoma: A critical assessment tool, sadly ignored!
    Oral Oncol. 2023;145:106528.
    >> Share

  393. LIU MD, Xue XM, Al-Aroomi MA, Xiong JJ, et al
    A novel flap design technique for subtotal tongue reconstruction with an "Individualized and Convenient Tongue Model".
    Oral Oncol. 2023;145:106531.
    >> Share

  394. SHIMODA H, Teshima M, Murase T, Nagao T, et al
    Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis.
    Oral Oncol. 2023;145:106491.
    >> Share

  395. CHEN S, Yang Y, Wang R, Fang J, et al
    Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis.
    Oral Oncol. 2023;145:106479.
    >> Share

  396. MISRA SR, Das R
    Early Discovery, Early Recovery: The principle behind successful oral squamous cell carcinoma treatment!
    Oral Oncol. 2023;145:106511.
    >> Share

  397. BANAVAR G, Ogundijo O, Julian C, Toma R, et al
    Detecting salivary host and microbiome RNA signature for aiding diagnosis of oral and throat cancer.
    Oral Oncol. 2023;145:106480.
    >> Share

  398. TURNER MT, Chung J, Noorkbash S, Topf MC, et al
    Complications following salvage transoral robotic surgery with and without reconstruction: A systematic review of the literature.
    Oral Oncol. 2023;145:106467.
    >> Share

    September 2023
  399. SHAIKH MH, Dawson A, Prokopec SD, Barrett JW, et al
    Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.
    Oral Oncol. 2023;146:106580.
    >> Share

  400. CAVALIERI S, Platini F, Barretta F, Nuzzolese I, et al
    Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
    Oral Oncol. 2023;146:106579.
    >> Share

  401. MALI SB
    Role of in vivo imaging in Head and Neck cancer management.
    Oral Oncol. 2023;146:106575.
    >> Share

  402. CHOI SY, Shim J, Gu DE, Kim SY, et al
    Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening.
    Oral Oncol. 2023;146:106571.
    >> Share

  403. GUO J, He Y, Lin C, Jiang Q, et al
    Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma.
    Oral Oncol. 2023;146:106574.
    >> Share

  404. SINGH R, Song S
    Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2023;146:106493.
    >> Share

  405. SHAH R, Tyagi S, Liu C, Judson B, et al
    Extra imaging beyond NCCN surveillance guidelines is cost effective for HPV- but not HPV+ oropharyngeal cancer.
    Oral Oncol. 2023;146:106564.
    >> Share

  406. MANN JE, Smith JD, Kulkarni A, Foltin SK, et al
    Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
    Oral Oncol. 2023;146:106562.
    >> Share

  407. JONASSON K, Sjovall J, Holmberg E, Beran M, et al
    Squamous cell carcinoma of the mobile tongue in young adults: A Swedish head & neck cancer register (SweHNCR) population-based analysis of prognosis in relation to age and stage.
    Oral Oncol. 2023;144:106485.
    >> Share

  408. HOFMANN E, Priebe J, Rieke DT, Doll C, et al
    Prognostic factors in surgically treated malignant salivary gland tumors.
    Oral Oncol. 2023;144:106484.
    >> Share

  409. DE FREITAS NEIVA LESSA A, Meirelles DP, Do Couto AM, Duarte Da Silva K, et al
    Scales to graduate oral mucositis: What are the limitations?
    Oral Oncol. 2023;144:106489.
    >> Share

  410. NOROUZI A, Liaghat M, Bakhtiyari M, Noorbakhsh Varnosfaderani SM, et al
    The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2023;144:106483.
    >> Share

  411. SAHA S, Patil VM, Noronha V, Menon N, et al
    Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre study.
    Oral Oncol. 2023;144:106486.
    >> Share

  412. ANDERSON EM, Luu M, Chung EM, Gay C, et al
    Re-examining predictors of pathologic lymph node positivity in clinically node negative oral cavity cancer.
    Oral Oncol. 2023;144:106490.
    >> Share

  413. MALI SB
    Molecular screening of head neck cancer.
    Oral Oncol. 2023;144:106481.
    >> Share

  414. FERNANDEZ FORNE A, Garcia Anaya MJ, Segado Guillot SJ, Plaza Andrade I, et al
    Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review.
    Oral Oncol. 2023;144:106488.
    >> Share

  415. KIM S, Lee C, Kim H, Yoon SO, et al
    Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
    Oral Oncol. 2023;144:106466.
    >> Share

  416. CANAHUATE G, Wentzel A, Mohamed ASR, van Dijk LV, et al
    Spatially-aware clustering improves AJCC-8 risk stratification performance in oropharyngeal carcinomas.
    Oral Oncol. 2023;144:106460.
    >> Share

  417. KIM DG, Choi SY
    Regional and distal metastases of mammary analog secretory carcinoma in the parotid gland.
    Oral Oncol. 2023;144:106463.
    >> Share

  418. SILVA LC, Faustino ISP, Ramos JC, Colafemina ACE, et al
    The importance of early treatment of oral squamous cell carcinoma: Case report.
    Oral Oncol. 2023;144:106442.
    >> Share

    August 2023
  419. VIEIRA GS, Perin MY, Figueiredo-Maciel T, Risuenho AJG, et al
    Induction chemotherapy response of HPV-related multiphenotypic sinonasal carcinoma: First-ever reported therapeutic outcome and a brief literature review.
    Oral Oncol. 2023;146:106555.
    >> Share

  420. XU YC, Chen KH, Liang Y, Chen KQ, et al
    Efficacy of induction chemotherapy in lymph node-positive stage III nasopharyngeal carcinoma and identification of beneficiaries based on clinical features: A propensity score matching analysis.
    Oral Oncol. 2023;146:106554.
    >> Share

  421. TASOULAS J, Schrank TP, Smith BD, Agala CB, et al
    Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemic.
    Oral Oncol. 2023;146:106535.
    >> Share

  422. CHARTERS E, Loy J, Wu R, Cheng K, et al
    Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: Restorabite(TM).
    Oral Oncol. 2023;146:106558.
    >> Share

  423. AL-MANEI K, Sobkowiak MJ, Nagadia RH, Heymann R, et al
    Mycobiota profile of oral fungal infections in head and neck cancer patients receiving radiotherapy: A 6-year retrospective MALDI-TOF mass spectrometry study.
    Oral Oncol. 2023;146:106556.
    >> Share

  424. PENAFORT PVM, Roza ALOC, Kussaba ST, de Brot Andrade L, et al
    Exuberant clear cell odontogenic carcinoma of the mandible harboring EWSR1 rearrangement: Report of a rare case and a literature review.
    Oral Oncol. 2023;143:106462.
    >> Share

  425. DAROONPAN P, Ouchi R, Zhang C, Nagai S, et al
    Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.
    Oral Oncol. 2023;143:106458.
    >> Share

  426. QIU Z, Wu Z, Zhou X, Lin F, et al
    Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy.
    Oral Oncol. 2023;143:106443.
    >> Share

  427. ZHANG L, Liao Y
    Comment on: Efficacy of Anti-PD1 blockade in treating recurrent or metastatic nasopharyngeal cancer: A systematic review and meta-analysis.
    Oral Oncol. 2023;143:106435.
    >> Share

  428. REGHUNADHAN P, Hegde S, Thakur S, Subash A, et al
    Outcomes for recurrent oral cavity squamous cell carcinoma: A comprehensive outlook.
    Oral Oncol. 2023;143:106440.
    >> Share

  429. URKEN ML, Yun J, Saturno MP, Greenberg LA, et al
    Frozen Section Analysis in Head and Neck Surgical Pathology: A Narrative Review of the Past, Present, and Future of Intraoperative Pathologic Consultation.
    Oral Oncol. 2023;143:106445.
    >> Share

  430. BHAMBHANI C, Sandford E, Haring CT, Brummel C, et al
    Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
    Oral Oncol. 2023;143:106436.
    >> Share

    July 2023
  431. DOLL C, Bigus S, Hofmann E, Mrosk F, et al
    Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection.
    Oral Oncol. 2023;145:106494.
    >> Share

  432. GAN M, Harris JP, Truong A, Nabar R, et al
    Timing of chemotherapy and radiation delivery for patients receiving chemoradiation for head and neck cancer: When does "concurrent" mean concurrent?
    Oral Oncol. 2023;145:106492.
    >> Share

  433. MULLER M, Li J, Giger R, Elicin O, et al
    Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge - A systematic review.
    Oral Oncol. 2023;145:106529.
    >> Share

  434. WEI F, Fang R, Lyu K, Liao J, et al
    Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage.
    Oral Oncol. 2023;145:106532.
    >> Share

  435. WATSON E, El Maghrabi A, Lee JH, Pu J, et al
    Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients.
    Oral Oncol. 2023;145:106527.
    >> Share

  436. NEWMAN S, Cowart JH, Omar N, Martin E, et al
    HPV-associated oropharyngeal Adenosquamous carcinoma with early metastatic disease detected by ctDNA.
    Oral Oncol. 2023;145:106526.
    >> Share

  437. HAN N, Zhou D, Ruan M, Yan M, et al
    Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer.
    Oral Oncol. 2023;145:106524.
    >> Share

  438. NGAMPHAIBOON N, Chairoungdua A, Dajsakdipon T, Jiarpinitnun C, et al
    Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma.
    Oral Oncol. 2023;145:106520.
    >> Share

  439. WANG G, Dong Z, Huang C, Du X, et al
    The value of integrating tumor volume and plasma Epstein-Barr virus DNA load during sequential chemoradiotherapy for prognostic prediction and therapeutic guidance in high-risk locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2023;145:106500.
    >> Share

  440. VIMALRAJ S, Sekaran S
    Exploring the potential of MiRNAs as predictive biomarkers for radioresistance in nasopharyngeal carcinoma.
    Oral Oncol. 2023;145:106521.
    >> Share

  441. YOKOTA Y, Hasegawa T, Yamakawa N, Rin S, et al
    Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.
    Oral Oncol. 2023;145:106519.
    >> Share

  442. KO K, Takahashi T, Honda K, Horii A, et al
    Avoiding total thyroidectomy for ectopic papillary thyroid carcinoma arising from the lateral neck.
    Oral Oncol. 2023;145:106501.
    >> Share

  443. LI D, Li C, Shi S
    Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.
    Oral Oncol. 2023;145:106497.
    >> Share

  444. PENG WS, Xing X, Li YJ, Ding JH, et al
    Prognostic nomograms for nasopharyngeal carcinoma with nodal features and potential indication for N staging system: Validation and comparison of seven N stage schemes.
    Oral Oncol. 2023;144:106438.
    >> Share

  445. ZENGA J, Awan M, Hadi Razeghi Kondelaji M, Hansen C, et al
    Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer.
    Oral Oncol. 2023;144:106487.
    >> Share

  446. CHEPEHA DB, Esemezie AO, Philteos J, Brown DH, et al
    Glossectomy for the treatment of oral cavity carcinoma: Quantitative, functional and patient-reported quality of life outcomes differ by four glossectomy defects.
    Oral Oncol. 2023;142:106431.
    >> Share

  447. SULTANIA M, Das Majumdar SK, Raghuram K, Ganapathy A, et al
    A rare case of cavernous sinus thrombosis following oral squamous cell carcinoma - The etiology and management dilemma.
    Oral Oncol. 2023;142:106421.
    >> Share

  448. EVERTON ASSUNCAO RIBEIRO DA CO, Luz Santos I, Julia Andrade Pereira Soares M, Dos Reis de Paula I, et al
    A case of metastatic NUT carcinoma of the nasal cavity.
    Oral Oncol. 2023;142:106432.
    >> Share

  449. HOLCOMB AJ, Farrokhian N, Tolan C, Whiteford E, et al
    Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
    Oral Oncol. 2023;142:106420.
    >> Share

    June 2023
  450. HE M, Gouda M, Gires O
    EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer.
    Oral Oncol. 2023;143:106465.
    >> Share

  451. YEUNG C, Meyers BM, Kartolo A
    Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?
    Oral Oncol. 2023;143:106444.
    >> Share

  452. KOYUNCU CF, Frederick MJ, Thompson LDR, Corredor G, et al
    Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients.
    Oral Oncol. 2023;143:106459.
    >> Share

  453. PANDIAR D, Nayanar SK, Nair V
    Papillary thyroid carcinoma arising in thyroglossal duct cyst: A case report with long term follow-up.
    Oral Oncol. 2023;143:106439.
    >> Share

  454. RUSSO E, Alessandri-Bonetti M, Costantino A, Festa BM, et al
    Functional outcomes and complications of total glossectomy with laryngeal preservation and flap reconstruction: A systematic review and meta-analysis.
    Oral Oncol. 2023;141:106415.
    >> Share

  455. YU Y, Schoder H, Zakeri K, Chen L, et al
    Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
    Oral Oncol. 2023;141:106400.
    >> Share

  456. ZHANG L, Judd RT, Zhao S, Rygalski C, et al
    Immediate resection of positive margins improves local control in oral tongue cancer.
    Oral Oncol. 2023;141:106402.
    >> Share

    May 2023
  457. UMEMORI K, Ono K, Eguchi T, Kawai H, et al
    EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
    Oral Oncol. 2023;142:106433.
    >> Share

  458. HIGGINSON JA, Breik O, Thompson AH, Ashrafian H, et al
    Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: A meta-analysis.
    Oral Oncol. 2023;142:106419.
    >> Share

  459. WARNAKULASURIYA S
    "Textbook outcome" as a quality metric of care in predicting survival from oral cancer.
    Oral Oncol. 2023;141:106416.
    >> Share

  460. DING H, Wu C, Sun W, Zhan Q, et al
    NUDT5-Determines the fate of head and neck squamous cell carcinoma cells under endoplasmic reticulum stress by catalyzing nuclear ATP production to promote DNA repair.
    Oral Oncol. 2023;141:106397.
    >> Share

  461. WANG Y, Gao Y, Yuan L, Zhang J, et al
    Retraction notice to "Psychological needs and associated factors among perioperative patients with oral cancer" [Oral Oncol. 123 (2021) 105615].
    Oral Oncol. 2023 May 5:106394. doi: 10.1016/j.oraloncology.2023.106394.
    >> Share

  462. RETTIG EM, Waterboer T, Sim E, Faden DL, et al
    Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis.
    Oral Oncol. 2023;141:106417.
    >> Share

  463. ALBERGA JM, Meijer J, Raghoebar GM, Langendijk JA, et al
    Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions.
    Oral Oncol. 2023;140:106392.
    >> Share

  464. MIAO HJ, Sun SK, Tian YY, Yang YQ, et al
    Oncologic safety of the pedicled submental island flap for reconstruction in oral tongue squamous cell carcinoma: An analysis of 101 cases.
    Oral Oncol. 2023;140:106395.
    >> Share

  465. REGHUNADHAN P, Hegde S, Thakur S, Subash A, et al
    Preoperative prediction model in salvage surgery for oral cavity squamous cell carcinoma: Precision before Assertion.
    Oral Oncol. 2023;140:106390.
    >> Share

  466. WANG T, Sun S, Zeng X, Li J, et al
    ICI-based therapies: A new strategy for oral potentially malignant disorders.
    Oral Oncol. 2023;140:106388.
    >> Share

  467. XI Y, Negrao MV, Akagi K, Xiao W, et al
    Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
    Oral Oncol. 2023;140:106372.
    >> Share

  468. CAO Y, Yao H
    Comment on: Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons.
    Oral Oncol. 2023;140:106370.
    >> Share

  469. HUA Y, Huang X, Li C, Gao N, et al
    An epulis-like camrelizumab related reactive cutaneous capillary endothelial proliferation (RCCEP) in the oral cavity: A case report.
    Oral Oncol. 2023;140:106369.
    >> Share

  470. ZHUGE L, Cai H, Huang Z, Wang S, et al
    The optimal number of examined lymph nodes for accurate nodal staging and favorable prognosis of oral tongue squamous cell carcinoma.
    Oral Oncol. 2023;140:106368.
    >> Share

    April 2023
  471. MISRA SR, Mohapatra SSG, Das R
    Comment on "Elective neck dissection: Desideratum or overkill?".
    Oral Oncol. 2023;141:106403.
    >> Share

  472. HUE J, Valinciute Z, Thavaraj S, Veschini L, et al
    Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
    Oral Oncol. 2023;141:106399.
    >> Share

  473. BOSCOLO-RIZZO P, Tirelli G, Polesel J, Sia E, et al
    TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance.
    Oral Oncol. 2023;140:106398.
    >> Share

  474. YANG TH, Xirasagar S, Cheng YF, Chen CS, et al
    Trends in the incidence of head and neck cancer: A nationwide population-based study.
    Oral Oncol. 2023;140:106391.
    >> Share

  475. MERCHANT YP, Shah A
    Elective neck dissection: Desideratum or overkill?
    Oral Oncol. 2023;140:106389.
    >> Share

  476. ARAUJO ALD, Moraes MC, Perez-de-Oliveira ME, Silva VMD, et al
    Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis.
    Oral Oncol. 2023;140:106386.
    >> Share

  477. LU H, Liu S, Xu W, Yang W, et al
    "Cervical metastasis" of recurrent pleomorphic adenoma of the submandibular gland: A new perspective for multifocal of recurrent pleomorphic adenoma.
    Oral Oncol. 2023;139:106355.
    >> Share

  478. PATEL ND, Cabrera CI, Fowler NM, Li S, et al
    Incidence and medical complications of COVID-19 in the total laryngectomy population: A population-based study.
    Oral Oncol. 2023;139:106353.
    >> Share

  479. MALI SB
    Surveillance of head neck cancer: Case for personalized and standardized surveillance.
    Oral Oncol. 2023;139:106354.
    >> Share

  480. ARVIND B, Tazeen S, Thakur S, Rao VUS, et al
    Upper oral cavity tumors: Is the risk of nodal metastasis different?
    Oral Oncol. 2023;139:106356.
    >> Share

  481. BIRKELAND AC, Kademani D, Moore MG, Blair EA, et al
    Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons.
    Oral Oncol. 2023;139:106341.
    >> Share

  482. CHARTERS E, Cheng K, Dunn M, Clark JR, et al
    Letter to the editor quantification of the force applied by the Therabite(R) Activeband.
    Oral Oncol. 2023;139:106335.
    >> Share

  483. DAS R, Misra SR
    Magnetic resonance imaging in the preoperative evaluation of depth of invasion in oral squamous carcinoma tongue: A few points to consider!
    Oral Oncol. 2023;139:106337.
    >> Share

  484. COMER JC, Harris AB, Hess AO, Hitchcock KE, et al
    Does lymphovascular invasion predict survival in oral cancer? A population-based analysis.
    Oral Oncol. 2023;140:106387.
    >> Share

    March 2023
  485. ZUO N, Ma L, Liu T, Hu W, et al
    Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
    Oral Oncol. 2023;140:106367.
    >> Share

  486. SAMPIERI C, Costantino A, Pirola F, Kim D, et al
    Neoadjuvant chemotherapy combined with transoral robotic surgery for stage III and IV laryngeal and hypopharyngeal carcinomas.
    Oral Oncol. 2023;140:106371.
    >> Share

  487. HERNANDO-CALVO A, Mirallas O, Marmolejo D, Saavedra O, et al
    Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients.
    Oral Oncol. 2023;140:106364.
    >> Share

  488. CHIEN CY, Wang CP, Lee LY, Lee SR, et al
    Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study.
    Oral Oncol. 2023;140:106366.
    >> Share

  489. LAMBERT T, Tasoulas J, Flores M, Sheth S, et al
    Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2023;140:106361.
    >> Share

  490. SCHEFF NN, Nilsen ML, Li J, Harris AL, et al
    The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Oral Oncol. 2023;140:106363.
    >> Share

  491. BANOUB RG, Crippen MM, Fiorella MA, Ross HM, et al
    Variance in 3D anatomic localization of surgical margins based on conventional margin labeling in head and neck squamous cell carcinoma.
    Oral Oncol. 2023;139:106360.
    >> Share

  492. ZHANG L, Freeman T, Sun S, Bhateja P, et al
    The use of plasma circulating tumor DNA for early detection of oligometastatic disease in HPV positive oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2023;139:106357.
    >> Share

  493. DE FELICE F
    Docetaxel plus radiotherapy for head and neck cancer.
    Oral Oncol. 2023;139:106359.
    >> Share

  494. ECONOMOPOULOU P, Spathis A, Kotsantis I, Maratou E, et al
    Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
    Oral Oncol. 2023;139:106358.
    >> Share

  495. RAMBEAU A, Alidra A, Riot A
    Metastatic lymphoepithelial carcinoma of the parotid gland: A case of prolonged response with platinum-gemcitabine regimen.
    Oral Oncol. 2023;138:106315.
    >> Share

  496. MERCHANT YP, Shetty S, Jayaraj R, Gopalakrishnan D, et al
    Depth of invasion in oral squamous carcinoma - More to this than meets the eye!
    Oral Oncol. 2023;138:106327.
    >> Share

  497. DE SOUSA LG, Lazar Neto F, Dal Lago EA, Sikora A, et al
    Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma.
    Oral Oncol. 2023;138:106311.
    >> Share

  498. SEKAR D
    Authors reply referring to the article published in oral oncology entitled Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs.
    Oral Oncol. 2023;138:106314.
    >> Share

    February 2023
  499. LI SC, Deng SW, Sun XS, Lan KQ, et al
    A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (>/=2 lines) anti-programmed death-1 monotherapy.
    Oral Oncol. 2023;139:106336.
    >> Share

  500. GUERLAIN J, Marhic A, Casiraghi O, Lumbroso J, et al
    Occult nodal metastases in T1-T2cN0 oral squamous cell carcinoma: Correlation between sentinel node positivity and completion neck dissection analysis.
    Oral Oncol. 2023;139:106338.
    >> Share

  501. PARIKH AS, Yu VX, Flashner S, Okolo OB, et al
    Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer.
    Oral Oncol. 2023;138:106330.
    >> Share

  502. XIAO Y, Mao L, Yang QC, Wang S, et al
    CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer.
    Oral Oncol. 2023;138:106331.
    >> Share

  503. RYGALSKI CJ, Huttinger ZM, Zhao S, Brock G, et al
    High surgical volume is associated with improved survival in head and neck cancer.
    Oral Oncol. 2023;138:106333.
    >> Share

  504. BALLAL Y, Gete M, Su J, O'Sullivan B, et al
    The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis.
    Oral Oncol. 2023;138:106332.
    >> Share

  505. BOOT PA, Mes SW, de Bloeme CM, Martens RM, et al
    Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2023;137:106307.
    >> Share

  506. HELLER MA, Nyirjesy SC, Balsiger R, Talbot N, et al
    Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis.
    Oral Oncol. 2023;137:106300.
    >> Share

  507. SEKAR D
    Authors reply to the comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
    Oral Oncol. 2023;137:106306.
    >> Share

  508. LASSCHE G, van Engen-van Grunsven ACH, van Hooij O, Aalders TW, et al
    Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
    Oral Oncol. 2023;137:106297.
    >> Share

  509. TERENZI V, Martellucci S, Dal Cortivo F, Stolfa A, et al
    Malignant trichilemmal carcinoma misdiagnosed with parotid gland malignant tumor.
    Oral Oncol. 2023;137:106303.
    >> Share

  510. BURNHAM AJ, Boyce BJ, Kaka AS, El-Deiry MW, et al
    Survival and functional outcomes after total glossectomy with total laryngectomy: Case series from a high-volume tertiary institution.
    Oral Oncol. 2023;137:106301.
    >> Share

  511. ZHANG S, Han X, Wang M, Shen X, et al
    Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
    Oral Oncol. 2023;137:106298.
    >> Share

  512. MARTINS FMC, Neto TH, Martins SP, Mendes RB, et al
    Metastasis to the oral cavity and jaw bones - A literature review about a case.
    Oral Oncol. 2023;137:106276.
    >> Share

    January 2023
  513. VAN BEERS MA, Schreuder WH, Balm AJM, van Dijk BAC, et al
    Is locally advanced head and neck cancer 'increasing' in the Netherlands? The paradox of absolute numbers, standardized incidence rates and proportional share.
    Oral Oncol. 2023;138:106316.
    >> Share

  514. PELLET A, Bertolus C, Saintigny P, Foy JP, et al
    Reliability of gene-expression profiling from tumor biopsy for refining neoadjuvant strategies in patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2023;138:106310.
    >> Share

  515. ROBBINS Y, Friedman J, Redman J, Sievers C, et al
    Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer.
    Oral Oncol. 2023;138:106309.
    >> Share

  516. WINNAND P, Ooms M, Heitzer M, Lammert M, et al
    Real-time detection of bone-invasive oral cancer with laser-induced breakdown spectroscopy: A proof-of-principle study.
    Oral Oncol. 2023;138:106308.
    >> Share

  517. WU Z, Han Y, Wan Y, Hua X, et al
    Oral microbiome and risk of incident head and neck cancer: A nested case-control study.
    Oral Oncol. 2023;137:106305.
    >> Share

  518. ARGYRIS PP, Saavedra F, Malz C, Stone IA, et al
    Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
    Oral Oncol. 2023;137:106304.
    >> Share

  519. HALLER TJ, Yin XL, O'Byrne TJ, Moore EJ, et al
    30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).
    Oral Oncol. 2023;137:106248.
    >> Share

  520. SUNAVALA-DOSSABHOY G, Petti S
    Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review.
    Oral Oncol. 2023;136:106280.
    >> Share

  521. ADEOYE J, Zheng LW, Thomson P, Choi SW, et al
    Explainable ensemble learning model improves identification of candidates for oral cancer screening.
    Oral Oncol. 2023;136:106278.
    >> Share

  522. VOIZARD B, Khoury M, Saydy N, Nelson K, et al
    Preoperative evaluation of depth of invasion in oral tongue squamous cell carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2023;136:106273.
    >> Share

  523. BOSSI P, Lorini L, Cosentini D, Grisanti S, et al
    Is it time to tailor treatments in androgen receptor positive salivary gland cancers?
    Oral Oncol. 2023;136:106274.
    >> Share

  524. YANG X, Liu L, Shen X, Shi L, et al
    Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs.
    Oral Oncol. 2023;136:106277.
    >> Share

  525. PAN Y, Li Y, Yuan F, Lin Z, et al
    A remarkable clinical response to immune checkpoint inhibitors of MSI-H high grade Mucoepidermoid carcinoma of the parotid gland with multiple metastases in the abdominal cavity.
    Oral Oncol. 2023;136:106190.
    >> Share

  526. THARAKAN T, Marfowaa G, Akakpo K, Jackson R, et al
    Multiple simultaneous free flaps for head and neck reconstruction: A multi-institutional cohort.
    Oral Oncol. 2023;136:106269.
    >> Share

  527. MERCHANT YP, Shetty CR, Shetty S
    Hormonal therapy in salivary gland malignancies: A mirage or magic?
    Oral Oncol. 2023;136:106267.
    >> Share

  528. ZHANG S, Deng Y, Ji T, Wang Y, et al
    Overestimated risk of transformation in oral lichen planus: In reply with emphasis on natural history of proliferative verrucous leukoplakia.
    Oral Oncol. 2023;136:106263.
    >> Share

  529. LAFUENTE-IBANEZ DE MENDOZA I, Aguirre-Urizar JM
    Letter to the editor referring to the publication entitled ''A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma!" by Das et al.
    Oral Oncol. 2023;136:106262.
    >> Share

  530. LEE MK, Choi Y
    Correlation between radiologic depth of invasion and pathologic depth of invasion in oral cavity squamous cell carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2023;136:106249.
    >> Share

  531. YEO BSY, Song HJJMD, Soong YL, Chua MLK, et al
    Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis.
    Oral Oncol. 2023;136:106242.
    >> Share

    December 2022
  532. IDA S, Takahashi H, Tada H, Mito I, et al
    Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
    Oral Oncol. 2022;137:106296.
    >> Share

  533. GHEENA S, Ezhilarasan D
    Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients.
    Oral Oncol. 2022;137:106282.
    >> Share

  534. DE FELICE F, Bossi P
    Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Hypothesis coming from the subgroup analysis.
    Oral Oncol. 2022;137:106275.
    >> Share

  535. PERES MA, Huihua L, Antunes JLF, Perea LME, et al
    Time trend and Age-Period-Cohort analysis of potentially HPV-related oral and pharyngeal cancer incidence in Singapore between 1968 and 2017.
    Oral Oncol. 2022;136:106272.
    >> Share

  536. TAZEEN S, Suri H, Lakshmi R, Subash A, et al
    Swallowing: A delayed milestone post-surgery in tongue cancers.
    Oral Oncol. 2022;135:106238.
    >> Share

  537. TAVERNA F, Alfieri S, Rebecca R, Giulia C, et al
    Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area.
    Oral Oncol. 2022;135:106229.
    >> Share

  538. GAO X, Tian K, Huang L, Chen J, et al
    Introducing the thin and ultrathin submental artery perforator flaps for precise reconstruction following T1-2 oral cavity cancer resection.
    Oral Oncol. 2022;135:106234.
    >> Share

  539. SMITH JD, Bellile EL, Ellsperman SE, Heft-Neal ME, et al
    Prognostic value of CD103(+) tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma.
    Oral Oncol. 2022;135:106226.
    >> Share

  540. GUNAWARDENA DA, Howes D, Fleming S, Clark J, et al
    Reconstruction of a maxillectomy and rhinectomy defect utilising a novel subperiosteal prosthesis and magnet-retained nasal prosthesis: A case report.
    Oral Oncol. 2022;135:106222.
    >> Share

  541. MISSALE F, Marchi F, Iandelli A, Subramaniam N, et al
    Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer.
    Oral Oncol. 2022;135:106210.
    >> Share

  542. HENDRIKS T, Flukes S
    Unknown primary Merkel cell carcinoma of the head and neck: Favourable outcomes with definitive radiotherapy.
    Oral Oncol. 2022;135:106228.
    >> Share

  543. TAZEEN S, Lal R, Kp A, Thakur S, et al
    Molecular and hormonal targets for malignant salivary gland tumors.
    Oral Oncol. 2022;135:106225.
    >> Share

  544. DE KONING KJ, van Es RJJ, Breimer GE, de Bree R, et al
    Response to: Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue.
    Oral Oncol. 2022;135:106199.
    >> Share

  545. TANG KD, Weeramange CE, Vider J, Hartel G, et al
    Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma.
    Oral Oncol. 2022;135:106215.
    >> Share

  546. TAPIA M, Manji J, Dhillon K, Kleid S, et al
    The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
    Oral Oncol. 2022;135:106213.
    >> Share

  547. LASSCHE G, van Boxtel W, Aalders TW, van Hooij O, et al
    Development and characterization of patient-derived salivary gland cancer organoid cultures.
    Oral Oncol. 2022;135:106186.
    >> Share

  548. MALI SB
    Epigenetics: Promising journey so far but ways to go in head neck cancer.
    Oral Oncol. 2022;135:106194.
    >> Share

  549. SARAVANAN M
    Constitutive activation of activator protein-1 as a cellular switch and its innovative role in the development of molecular targets for tongue squamous cell carcinoma treatment.
    Oral Oncol. 2022;135:106198.
    >> Share

  550. KHADEMBASCHI D, Jafri M, Praveen P, Parmar S, et al
    Does neoadjuvant chemotherapy provide a survival benefit in maxillofacial osteosarcoma: A systematic review and pooled analysis.
    Oral Oncol. 2022;135:106133.
    >> Share

  551. PARK BJ, Mattox AK, Clayburgh D, Patel M, et al
    Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.
    Oral Oncol. 2022;135:106183.
    >> Share

    November 2022
  552. MITO I, Takahashi H, Kawabata-Iwakawa R, Horikawa M, et al
    Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;136:106270.
    >> Share

  553. KIRAN NAZEER P, Shaheen S, Shafique K, Sarfraz A, et al
    The role of precision medicine in head and neck cancer: A systematic study of ongoing clinical trials.
    Oral Oncol. 2022;136:106271.
    >> Share

  554. PENG Y, Liu Y, Shen G, Chen Z, et al
    Improved accuracy of auto-segmentation of organs at risk in radiotherapy planning for nasopharyngeal carcinoma based on fully convolutional neural network deep learning.
    Oral Oncol. 2022;136:106261.
    >> Share

  555. MANZOOR H, Rasheed A, Zeen F, Sarfraz A, et al
    Anti-PD-1 immunotherapy - Pembrolizumab current clinical trials for advanced head and neck cancer: A mapping systematic study.
    Oral Oncol. 2022;136:106266.
    >> Share

  556. LIU HC, Williamson CW, Zou J, Todd JR, et al
    Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy.
    Oral Oncol. 2022;136:106247.
    >> Share

  557. CHAN JYK, Cheung MK, Lan L, Ng C, et al
    Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
    Oral Oncol. 2022;135:106245.
    >> Share

  558. KMIECIK M, Nogal P, Banaszewski J, Wierzbicka M, et al
    Corrigendum to "Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report" [Oral Oncol. 134 (2022) 106135].
    Oral Oncol. 2022 Nov 4:106233. doi: 10.1016/j.oraloncology.2022.106233.
    >> Share

  559. QUAN T, Guan W, Huang W, Cui C, et al
    Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2022;135:106230.
    >> Share

  560. BISHESHAR SK, van der Kamp MF, de Ruiter EJ, Ruiter LN, et al
    The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Oral Oncol. 2022;135:106227.
    >> Share

  561. ERRAZQUIN R, Page A, Sunol A, Segrelles C, et al
    Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
    Oral Oncol. 2022;134:106184.
    >> Share

  562. CHIDAMBARAM S, Hong SA, Simpson MC, Osazuwa-Peters N, et al
    Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.
    Oral Oncol. 2022;134:106132.
    >> Share

  563. AROSIO AD, Bernasconi DP, Valsecchi MG, Pacifico C, et al
    Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers.
    Oral Oncol. 2022;134:106123.
    >> Share

  564. CONTRERA KJ, Zafereo ME, Yaniv D, Roberts DB, et al
    Outcomes for recurrent oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;134:106127.
    >> Share

  565. DAS R, Misra SR, Pradhan S
    A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma!
    Oral Oncol. 2022;134:106126.
    >> Share

  566. LIU Y, Bilodeau E, Pollack B, Batmanghelich K, et al
    Automated detection of premalignant oral lesions on whole slide images using convolutional neural networks.
    Oral Oncol. 2022;134:106109.
    >> Share

  567. TITINCHI F, Sallies M, Wu HT
    Mucoepidermoid carcinoma ex pleomorphic adenoma: A rare diagnostically challenging entity.
    Oral Oncol. 2022;134:106112.
    >> Share

  568. RAMASUBBU K, Devi Rajeswari V
    A novel target approach for epithelial-mesenchymal transitioning oral squamous cell carcinoma and their involvement of PI3K/Akt/mTOR and Hedgehog signaling pathway.
    Oral Oncol. 2022;134:106119.
    >> Share

  569. VILLEGAS KM, Paparella ML
    Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature.
    Oral Oncol. 2022;134:106068.
    >> Share

  570. YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
    Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.
    Oral Oncol. 2022;134:106120.
    >> Share

  571. CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
    MicroRNAs and cancer-associated fibroblasts in the tumour microenvironment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;134:106124.
    >> Share

  572. YASASVE M, Saravanan M
    Role of dysregulated miRNAs profiles as hallmarks in the pathogenesis and differential regulation of tongue squamous cell carcinoma.
    Oral Oncol. 2022;134:106104.
    >> Share

  573. ROH JL
    Superficial versus total parotidectomy for recurrent pleomorphic adenoma in the parotid gland.
    Oral Oncol. 2022;134:106103.
    >> Share

  574. SEKAR D, Selvakumar SC, Auxzilia Preethi K
    Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).
    Oral Oncol. 2022;134:106106.
    >> Share

  575. ELUMALAI P, Ezhilarasan D
    Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma.
    Oral Oncol. 2022;134:106100.
    >> Share

  576. MANJUSHA M, Saravanan M
    Oropharyngeal cancer associated with sarcopenic obesity and sarcopenic weight loss.
    Oral Oncol. 2022;134:106101.
    >> Share

  577. FITZGERALD CWR, Davies JC, de Almeida JR, Rich JT, et al
    Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study.
    Oral Oncol. 2022;134:106089.
    >> Share

  578. DE LUCA P, Scarpa A, Viola P, Motta G, et al
    Collision tumors of the larynx: A retrospective single-center case series of an extremely rare phenomenon.
    Oral Oncol. 2022;134:106096.
    >> Share

  579. TOPKAN E, Somay E, Yilmaz B, Kucuk A, et al
    Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
    Oral Oncol. 2022;134:106098.
    >> Share

  580. KAJO K, Othman BK, Kajova Machalekova K
    Sclerosing Warthin-like mucoepidermoid carcinoma of the salivary gland.
    Oral Oncol. 2022;134:106090.
    >> Share

  581. SEKARAN S, Ganapathy D
    Salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders.
    Oral Oncol. 2022;134:106065.
    >> Share

  582. FESTA BM, Costantino A, Ferreli F, Spriano G, et al
    The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores: Avoiding the wrong conclusion.
    Oral Oncol. 2022;134:106071.
    >> Share

  583. WEINBERGER JM, Abd El Qadir N, Hirshoren N
    Double trouble: A cohort study of re-irradiation and laryngectomy - Severity of and risk for pharyngocutaneous fistula.
    Oral Oncol. 2022;134:106069.
    >> Share

  584. DE BREE R, Leemans CR
    When to perform a paratracheal lymph node dissection during total laryngectomy?
    Oral Oncol. 2022;134:106048.
    >> Share

  585. WU B, Shen L, Peng G, Li Y, et al
    Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing.
    Oral Oncol. 2022;135:106218.
    >> Share

  586. HUANG J, Harris E, Lorch J
    Vaccination as a therapeutic strategy for Nasopharyngeal carcinoma.
    Oral Oncol. 2022;135:106083.
    >> Share

    October 2022
  587. XUE S, Song G, Zhu Y, Zhang N, et al
    The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis.
    Oral Oncol. 2022;135:106231.
    >> Share

  588. KAO DD, Ferrandino RM, Bauml JM, Marshall DC, et al
    Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck.
    Oral Oncol. 2022;135:106216.
    >> Share

  589. ZHU L, Li M, Tang G, Shi L, et al
    Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders - Reply.
    Oral Oncol. 2022;135:106224.
    >> Share

  590. DENNIS MJ, Sacco AG, Qi Y, Bykowski J, et al
    A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2022;135:106219.
    >> Share

  591. GOVINDARASU M, Prathap L, Govindasamy R
    Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway.
    Oral Oncol. 2022;135:106221.
    >> Share

  592. CHABRILLAC E, Lebars S, Breuskin I, Thariat J, et al
    Pregnancy-associated head and neck cancer:a partnership between theCORASSO patient association and theREFCOR physician networkto study a pathology of extremely rare occurrence.
    Oral Oncol. 2022;135:106223.
    >> Share

  593. OLAWUNI FO, Sauer AB, Daher GS, Douse DM, et al
    The reporting and representation of sex and gender in head and neck cancer clinical trials.
    Oral Oncol. 2022;135:106217.
    >> Share

  594. SUNDRAMOORTHY AK, Atchudan R, Arya S
    Utilization of Raman spectroscopy in biochemical fingerprint analysis for oral cancer screening and diagnosis.
    Oral Oncol. 2022;135:106192.
    >> Share

  595. ZHU L, Deng Y, Ji T, Zhou H, et al
    Metformin and oral cancer: In reply with emphasis on an emerging role of an old drug in oral cancer chemoprevention.
    Oral Oncol. 2022;135:106196.
    >> Share

  596. MANJUSHA M, Saravanan M
    Development of novel electrochemical based nano-biosensors for the diagnosis of oral potentially malignant disorders and oral carcinoma.
    Oral Oncol. 2022;135:106197.
    >> Share

  597. SEKAR AA, Veeraraghavan VP, Raj AT, Patil S, et al
    Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer.
    Oral Oncol. 2022;135:106195.
    >> Share

  598. GURMEET SINGH A, Sathe P, Roy S, Thiagrajan S, et al
    Incidence and impact of skip metastasis in the neck in early oral cancer: Reality or a myth?
    Oral Oncol. 2022;135:106201.
    >> Share

  599. KRISHNAMOORTHY K, Priya Veeraraghavan V, Jayaraman S
    E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;135:106193.
    >> Share

  600. ZHU S, Zhang F, Zhao G, Zhang X, et al
    Trends in the global burden of oral cancer joint with attributable risk factors: Results from the global burden of disease study 2019.
    Oral Oncol. 2022;134:106189.
    >> Share

  601. LIU W, Ji T, Zhang C, Zhou Q, et al
    Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
    Oral Oncol. 2022;134:106129.
    >> Share

  602. YU C, Zhou Z
    Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue.
    Oral Oncol. 2022;133:106057.
    >> Share

  603. FEENEY L, Hapuarachi B, Adderley H, Rack S, et al
    Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
    Oral Oncol. 2022;133:106028.
    >> Share

  604. MORING MM, Mast H, Wolvius EB, Verduijn GM, et al
    Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
    Oral Oncol. 2022;133:106056.
    >> Share

  605. AUXZILIA PREETHI K, Chandralekha Selvakumar S, Sekar D
    MicroRNAs and it's targets in the treatment of salivary adenoid cystic carcinoma.
    Oral Oncol. 2022;133:106053.
    >> Share

  606. KEY S, Chia C, Hasan Z, Sundaresan P, et al
    Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
    Oral Oncol. 2022;133:106052.
    >> Share

  607. ANGEL GONZALEZ-MOLES M, Ramos-Garcia P
    Overestimated risk of transformation in oral lichen planus: In reply.
    Oral Oncol. 2022;133:106045.
    >> Share

  608. DE KONING KJ, van Es RJJ, Klijn RJ, Breimer GE, et al
    Application and accuracy of ultrasound-guided resections of tongue cancer.
    Oral Oncol. 2022;133:106023.
    >> Share

  609. NGUYEN ML, Hsieh ML, Henson C, Krempl G, et al
    Neoadjuvant QUAD shot for downstaging or temporizing locally advanced oral cavity cancer prior to definitive surgery.
    Oral Oncol. 2022;133:106029.
    >> Share

  610. SARAVANAN M, Kolade Omole R, Torimiro N
    Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment.
    Oral Oncol. 2022;133:106021.
    >> Share

  611. CAI X, Zhang J, Zhang H, Li T, et al
    Overestimated risk of transformation in oral lichen planus.
    Oral Oncol. 2022;133:106025.
    >> Share

  612. SIVAPERUMAL P, Kamala K
    Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer.
    Oral Oncol. 2022;133:106020.
    >> Share

  613. HENG Y, Yang Z, Lin J, Liu Q, et al
    Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
    Oral Oncol. 2022;134:106185.
    >> Share

    September 2022
  614. MORSE RT, Beaty B, Scanga L, Blumberg J, et al
    Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;134:106131.
    >> Share

  615. ZHU GL, Fang XL, Yang KB, Tang LL, et al
    Development and validation of a joint model for dynamic prediction of overall survival in nasopharyngeal carcinoma based on longitudinal post-treatment plasma cell-free Epstein-Barr virus DNA load.
    Oral Oncol. 2022;134:106140.
    >> Share

  616. XUE F, Ou D, Ou X, Zhou X, et al
    Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2022;134:106139.
    >> Share

  617. SANKAR S
    New insights into CAR T-cell therapy for recurrent head and neck squamous cell carcinoma.
    Oral Oncol. 2022;134:106137.
    >> Share

  618. KMIECIK M, Nogal P, Wierzbicka M, Jackowska J, et al
    Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report.
    Oral Oncol. 2022;134:106135.
    >> Share

  619. GUPTA T, Kannan S, Ghosh-Laskar S, Agarwal JP, et al
    Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior?
    Oral Oncol. 2022;134:106130.
    >> Share

  620. HITT R, Mesia R, Lozano A, Iglesias Docampo L, et al
    Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.
    Oral Oncol. 2022;134:106087.
    >> Share

  621. ZHANG J, Wu HY, Lu Q, Shan XF, et al
    Effects of personalized swallowing rehabilitation in patients with oral cancer after free flap transplantation: A cluster randomized controlled trial.
    Oral Oncol. 2022;134:106097.
    >> Share

  622. PATIL V, Kumar S, Noronha V, Menon N, et al
    Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer.
    Oral Oncol. 2022;134:106085.
    >> Share

  623. SARODE GS, Anand R, Sharma NK, Sarode SC, et al
    Hot and cold tumor: Recent developments and perspectives on oral cancer.
    Oral Oncol. 2022;134:106114.
    >> Share

  624. BEOM HEO D, Piao Y, Hee Lee J, Ju SH, et al
    Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
    Oral Oncol. 2022;134:106115.
    >> Share

  625. SAHNI V, Kumar A, Gupta S, Sharma S, et al
    Metformin and oral cancer.
    Oral Oncol. 2022;134:106125.
    >> Share

  626. TOBIAS MAS, Nogueira BP, Santana MCS, Pires RG, et al
    Artificial intelligence for oral cancer diagnosis: What are the possibilities?
    Oral Oncol. 2022;134:106117.
    >> Share

  627. SHREE HARINI K, Ezhilarasan D, Elumalai P
    Restoring the anti-tumor property of PTEN: A promising oral cancer treatment.
    Oral Oncol. 2022;134:106113.
    >> Share

  628. NONG T, Medrano T, Marrero C, Rubens M, et al
    Radiation induced taste changes in head and neck cancer - differential impact of treatment factors.
    Oral Oncol. 2022;134:106105.
    >> Share

  629. MUTHUKRISHNAN L
    "TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)".
    Oral Oncol. 2022;134:106118.
    >> Share

  630. MONY U, Priya Veeraraghavan V
    "Rules" to the genetic progression of tumours deciphered: Is it time to think differently in treating oral cancer patients?
    Oral Oncol. 2022;134:106111.
    >> Share

  631. PRASAD M, Jayaraman S, Rajagopal P, Veeraraghavan VP, et al
    Apoptosis regulating CircRNAs: Emerging role in oral cancer therapeutics.
    Oral Oncol. 2022;134:106107.
    >> Share

  632. DE WIT JG, van Schaik JE, Voskuil FJ, Vonk J, et al
    Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery.
    Oral Oncol. 2022;134:106099.
    >> Share

  633. VILASECA I, Xavier Aviles-Jurado F, Lehrer E, Valduvieco I, et al
    CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy.
    Oral Oncol. 2022;134:106088.
    >> Share

  634. YUAN H, Yan M, Liang X, Liu W, et al
    Decoding the associations between cell functional states in head and neck cancer based on single-cell transcriptome.
    Oral Oncol. 2022;134:106110.
    >> Share

  635. BALACHANDER K, Vijayashree Priyadharsini J, Paramasivam A
    Advances in oral cancer early diagnosis and treatment strategies with liquid biopsy-based approaches.
    Oral Oncol. 2022;134:106108.
    >> Share

  636. TAKENAKA Y, Takemoto N, Otsuka T, Nishio M, et al
    Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study.
    Oral Oncol. 2022;132:106018.
    >> Share

  637. LIU AQ, Deane EC, Heffernan A, Ji Y, et al
    Patient-reported outcomes and morbidity after head and neck reconstructions: An evaluation of fibular and scapular free flaps.
    Oral Oncol. 2022;132:106019.
    >> Share

  638. SHAH HP, Cohen O, Sukys J, Dibble J, et al
    The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores.
    Oral Oncol. 2022;132:106006.
    >> Share

  639. AMITH K P, V Lal R, Lakshmi Pandey R, Thakur S, et al
    Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma - "Need for incorporation of sub classification of pT4b lesions".
    Oral Oncol. 2022;132:106014.
    >> Share

  640. CHABRILLAC E, Jackson R, Mattei P, D'Andrea G, et al
    Paratracheal lymph node dissection during total (pharyngo-)laryngectomy: A systematic review and meta-analysis.
    Oral Oncol. 2022;132:106017.
    >> Share

  641. DAS R, Satya Sai Reddy Gontu G, Das K, Das A, et al
    Validation of ATA guidelines for Indian population: Do ATA guidelines have an impact on management of DTC patients in Indian population - A 5 year retrospective cohort analysis.
    Oral Oncol. 2022;132:106016.
    >> Share

  642. SOARES CD, Santana T, Lacerda de Souza L, Paes de Almeida O, et al
    Intraductal carcinoma of the submandibular gland: A case report.
    Oral Oncol. 2022;132:106010.
    >> Share

  643. K P A, Thakur S, Hanagvadi S, Siva Bharani KSN, et al
    "Haemophilia A" - Presenting with oral squamous cell carcinoma diagnosis and management strategies.
    Oral Oncol. 2022;132:105994.
    >> Share

  644. TASSONE P, Caruso C, White M, Tavares Dos Santos H, et al
    The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;132:106002.
    >> Share

  645. MARINHO MFP, Marinho MCFL, de Andrade BAB, Pinto MAVR, et al
    Oral squamous cell carcinoma clinically resembling BRONJ.
    Oral Oncol. 2022;132:105974.
    >> Share

  646. YANG X, Yang X, Ji T, Zhou Q, et al
    A bibliometric analysis of the papers on oral potentially malignant disorder in Oral Oncology.
    Oral Oncol. 2022;132:105996.
    >> Share

  647. FERRER-SANCHEZ A, Bagan J, Vila-Frances J, Magdalena-Benedito R, et al
    Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning.
    Oral Oncol. 2022;132:105967.
    >> Share

  648. CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
    Response to the comment on "The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations".
    Oral Oncol. 2022;132:105984.
    >> Share

  649. CABRAL RAMOS J, Cesar Silva L, Schausltz Pereira Faustino I, Carolina Evangelista Colafemina A, et al
    A rare case of squamous cell carcinoma of the gingiva: A diagnostic challenge.
    Oral Oncol. 2022;132:105995.
    >> Share

  650. DENG W, Zhao G, Li Z, Yang L, et al
    Recovery pattern analysis of swallowing function in patients undergoing total glossectomy and hemiglossectomy.
    Oral Oncol. 2022;132:105981.
    >> Share

  651. JACOBS CD, Barak I, Jung SH, Rocke DJ, et al
    Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers.
    Oral Oncol. 2022;132:105955.
    >> Share

  652. SIEVERT M, Oetter N, Mantsopoulos K, Gostian AO, et al
    Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinoma.
    Oral Oncol. 2022;132:105978.
    >> Share

    August 2022
  653. CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
    Non-coding RNAs influencing anti PD-1 immunotherapy in head and neck squamous cell carcinoma (HNSCC).
    Oral Oncol. 2022;134:106092.
    >> Share

  654. YADALAM PK, Anegundi RV, Ramadoss R, Joseph B, et al
    Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain.
    Oral Oncol. 2022;134:106094.
    >> Share

  655. SEMPRINI J
    Oral cancer screening prevalence in low-income adults before and after the ACA.
    Oral Oncol. 2022;134:106055.
    >> Share

  656. PAZHANI J, Veeraraghavan VP, Jayaraman S
    Aurora kinase in oral cancer: A potential therapeutic target to improve treatment efficiency.
    Oral Oncol. 2022;134:106093.
    >> Share

  657. KRUTZ M, Acharya P, Chissoe G, Raj V, et al
    Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival.
    Oral Oncol. 2022;134:106072.
    >> Share

  658. HEMPENIUS MA, Bisheshar SK, Slagter-Menkema L, van der Kamp MF, et al
    Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;134:106086.
    >> Share

  659. VAISH R, Mittal N, Mahajan A, Rane SU, et al
    Sentinel node biopsy in node negative early oral cancers: Solution to the conundrum!
    Oral Oncol. 2022;134:106070.
    >> Share

  660. MUTHUPANDIAN S, Muralidharan M, Madhavan Y, Hariharan NM, et al
    Prospective role of salivary MicroRNA for early detection - personalized therapy of head and neck squamous cell carcinoma.
    Oral Oncol. 2022;134:106063.
    >> Share

  661. PARAMASIVAM A
    Circulating circular RNAs: Novel potential biomarkers and therapeutic targets for oral cancer.
    Oral Oncol. 2022;134:106067.
    >> Share

  662. EZHILARASAN D, Shree Harini K
    Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy.
    Oral Oncol. 2022;133:106066.
    >> Share

  663. PRASAD M, Veeraraghavan VP, Jayaraman S
    Tumorigenic potential of GLUT4: A therapeutic target for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;133:106061.
    >> Share

  664. YU C, Zhou Z
    Relationship between young non-smokers and oral cancer: What can we learn?
    Oral Oncol. 2022;133:106064.
    >> Share

  665. REKHA K, Venkidasamy B, Govindasamy R, Neralla M, et al
    Isothiocyanates (AITC & BITC) bioactive molecules: Therapeutic potential for oral cancer.
    Oral Oncol. 2022;133:106060.
    >> Share

  666. BALACHANDER K, Abilasha R, Priyadharsini JV, Balamurugan R, et al
    Targeting mitochondria for apoptosis in oral cancer: Therapeutic potential and obstacles.
    Oral Oncol. 2022;133:106059.
    >> Share

  667. SARODE GS, Kumari N, Gophane R, Ghone U, et al
    Trends and prospects in oral cancer vaccine.
    Oral Oncol. 2022;133:106051.
    >> Share

  668. MA SJ, Yu H, Khan M, Yu B, et al
    Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
    Oral Oncol. 2022;133:106054.
    >> Share

  669. VERDONCK-DE LEEUW I, Dawson C, Licitra L, Eriksen JG, et al
    European Head and Neck Society recommendations for head and neck cancer survivorship care.
    Oral Oncol. 2022;133:106047.
    >> Share

  670. LU HJ, Peng CY, Tseng HC, Hsin CH, et al
    Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;131:105951.
    >> Share

  671. ZANOLETTI E, Tealdo G, Franz L, Cazzador D, et al
    From "Extended total parotidectomy" to "Temporo-parotid resection" for locally advanced parotid tumors: Outlining a shift in surgical perspective.
    Oral Oncol. 2022;131:105975.
    >> Share

  672. STANBOULY D, Philipone E, Morlandt AB, Kaleem A, et al
    Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes.
    Oral Oncol. 2022;131:105952.
    >> Share

  673. SIVAPERUMAL P, Sekaran S, Kamala K, Ganapathy D, et al
    Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;131:105971.
    >> Share

  674. WU Y, Koyuncu CF, Toro P, Corredor G, et al
    A machine learning model for separating epithelial and stromal regions in oral cavity squamous cell carcinomas using H&E-stained histology images: A multi-center, retrospective study.
    Oral Oncol. 2022;131:105942.
    >> Share

  675. HAN N, Li X, Wang Y, Li H, et al
    HIF-1alpha induced NID1 expression promotes pulmonary metastases via the PI3K-AKT pathway in salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;131:105940.
    >> Share

  676. DONA MG, Rollo F, Pichi B, Moretto S, et al
    Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
    Oral Oncol. 2022;131:105947.
    >> Share

    July 2022
  677. DASSE R, Dupin C, Gorphe P, Temam S, et al
    Proposal for an algorithm to avoid neck dissection during salvage total laryngectomy. A GETTEC multicentric study.
    Oral Oncol. 2022;133:106026.
    >> Share

  678. CHOW JCH, Lee AWM, Wong CHL, Ng WT, et al
    Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
    Oral Oncol. 2022;133:106031.
    >> Share

  679. KRISHNAN M, Venkidasamy B
    PEITC: A prospective natural metabolite in oral cancer treatment.
    Oral Oncol. 2022;133:106044.
    >> Share

  680. YU C, Zhou Z
    Assessment of oral dysfunction after oral cancer treatment.
    Oral Oncol. 2022;133:106046.
    >> Share

  681. SARODE GS, Sarode SC, Kumari N, Gophane R, et al
    FAP-targeted imaging in oral cancer: Critical viewpoints.
    Oral Oncol. 2022;133:106024.
    >> Share

  682. YASASVE M, Manjusha M, Saravanan M
    Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.
    Oral Oncol. 2022;133:106027.
    >> Share

  683. KONO M, Saito S, Egloff AM, Allen CT, et al
    The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.
    Oral Oncol. 2022;132:106012.
    >> Share

  684. MELO G, Silva CAB, Hague A, Parkinson EK, et al
    Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.
    Oral Oncol. 2022;132:105979.
    >> Share

  685. KUMARESAN V, Sivaperumal P, Smiline Girija AS
    Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells - Multifunctional therapeutic approach against oral cancer.
    Oral Oncol. 2022;132:106013.
    >> Share

  686. RENU K, Veeraraghavan VP, Raj A T, Patil S, et al
    The peroxisome proliferator-activated receptor-alpha (PPAR-alpha): A new therapeutic target for oral cancer.
    Oral Oncol. 2022;132:106007.
    >> Share

  687. ALLEN JL, Hames RA, Mastroianni NM, Greenstein AE, et al
    Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
    Oral Oncol. 2022;132:106008.
    >> Share

  688. SARODE GS, Kumari N, Sarode SC
    Oral cancer histopathology images and artificial intelligence: A pathologist's perspective.
    Oral Oncol. 2022;132:105999.
    >> Share

  689. DE VRIES J, Poelman A, Sidorenkov G, Festen S, et al
    The association of frailty and outcomes of geriatric assessment with acute radiation-induced toxicity in patients with head and neck cancer.
    Oral Oncol. 2022;130:105933.
    >> Share

  690. RIBEIRO MFA, Oliveira MCM, Leite AC, Bruzinga FFB, et al
    Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review.
    Oral Oncol. 2022;130:105936.
    >> Share

  691. KAZEMIAN E, Solinski M, Adams W, Moore M, et al
    The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105937.
    >> Share

  692. JAYARAMAN S, Sekar R, Veeraraghavan VP, Raj AT, et al
    MALAT 1 a modulator of PD-1/PD-L1 regulation in oral malignancies: An emerging target in cancer therapy.
    Oral Oncol. 2022;130:105950.
    >> Share

  693. FANG Y, Peng Z, Wang Y, Gao K, et al
    Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
    Oral Oncol. 2022;130:105945.
    >> Share

  694. MIN Y, Feng Y, He D, Zeng X, et al
    Is Age >/= 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study.
    Oral Oncol. 2022;130:105938.
    >> Share

  695. LI C, Zhang Q, Sun K, Jia H, et al
    Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study.
    Oral Oncol. 2022;130:105941.
    >> Share

  696. PONNIAH I
    "In response to "Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia".
    Oral Oncol. 2022;130:105944.
    >> Share

  697. MENDONCA P, Sunny SP, Mohan U, Birur N P, et al
    Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105877.
    >> Share

  698. KIL WJ
    Rapid physical and emotional palliation from QUAD shot radiotherapy to a frail elderly patient with stage IV parotid gland cancer-associated facial paralysis and pain when no other palliative intervention was available during COVID-19 pandemic.
    Oral Oncol. 2022;130:105930.
    >> Share

  699. SELVAKUMAR SC, K Auxzilia P, Dinesh Y, Senthilmurugan M, et al
    MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105925.
    >> Share

  700. KIONG KL, Moreno A, Vu CN, Zheng G, et al
    Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
    Oral Oncol. 2022;130:105906.
    >> Share

  701. MA P, Shen HY, Chen DS, Lu ZY, et al
    Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma.
    Oral Oncol. 2022;130:105905.
    >> Share

  702. TANG R, Mao S, Liu S, Li Z, et al
    Types of endoscopic surgical approaches for benign parapharyngeal space tumors.
    Oral Oncol. 2022;130:105875.
    >> Share

  703. DOLL C, Mrosk F, Wuester J, Runge AS, et al
    Pattern of cervical lymph node metastases in squamous cell carcinoma of the upper oral cavity - How to manage the neck.
    Oral Oncol. 2022;130:105898.
    >> Share

  704. MAZEROLLE P, Fuchsmann C, Schultz P, Benmoussa N, et al
    Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study.
    Oral Oncol. 2022;130:105896.
    >> Share

  705. VIGARIOS E, Warnakulasuriya S, Piau A, Giraudeau N, et al
    Early detection of oral malignancies may involve the development of tele-expertise in dentistry.
    Oral Oncol. 2022;130:105904.
    >> Share

  706. YANG X, Zhou T, Ji T, Jia H, et al
    Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105901.
    >> Share

  707. JAYASEELAN VP, A S SG, Arumugam P
    Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105874.
    >> Share

  708. EZHILARASAN D, Shree Harini K, Lakshmi T
    Osteopontin: A reliable diagnostic marker and an attractive therapeutic target in oral cancers.
    Oral Oncol. 2022;132:106005.
    >> Share

    June 2022
  709. MISRA SR, Das R
    Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!
    Oral Oncol. 2022;132:105998.
    >> Share

  710. BALACHANDER K, Paramasivam A
    Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?
    Oral Oncol. 2022;132:105997.
    >> Share

  711. BABU S, Krishnan M, Priya Veeraraghavan V, Jayaraman S, et al
    Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma.
    Oral Oncol. 2022;132:105993.
    >> Share

  712. ALESSANDRINI L, Ferrari M, Taboni S, Sbaraglia M, et al
    Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
    Oral Oncol. 2022;132:105982.
    >> Share

  713. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Novel fibroblast growth factor receptor inhibitors: Potential therapeutic approach in oral cancer treatment.
    Oral Oncol. 2022;132:105983.
    >> Share

  714. REVATHI D, Dhanraj G, Ashok V
    Immune check point inhibitors: A promising therapeutic approach in oral cancer.
    Oral Oncol. 2022;132:105977.
    >> Share

  715. SEKARAN S, Pitchaiah S, Ganapathy D
    Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?
    Oral Oncol. 2022;131:105973.
    >> Share

  716. ZONG J, Ji P, Lin C, Zhang R, et al
    Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.
    Oral Oncol. 2022;131:105972.
    >> Share

  717. BALACHANDER K, Paramasivam A
    Ferroptosis: An emerging therapeutic target for oral cancer.
    Oral Oncol. 2022;131:105970.
    >> Share

  718. GANAPATHY D, Sekaran S, Pitchaiah S
    Is prognostic monitoring of high-risk populations at risk for oral cancer necessary after infection with COVID-19?
    Oral Oncol. 2022;131:105968.
    >> Share

  719. LUO HD, Xia FJ, Wu JH, Yi B, et al
    Efficacy of chemoradiotherapy in survival of stage nasopharyngeal carcinoma and establishment of a prognostic model.
    Oral Oncol. 2022;131:105927.
    >> Share

  720. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Patient derived tumour organoids: An emerging strategy in oral cancer research and therapeutics.
    Oral Oncol. 2022;131:105954.
    >> Share

  721. VARGHESE BT, Nair SP, Janardhan D
    Transglottic intralaryngeal papillary thyroid carcinoma.
    Oral Oncol. 2022;131:105935.
    >> Share

  722. YANG Z, Liao J, Schumaker L, Carter-Cooper B, et al
    Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
    Oral Oncol. 2022;131:105939.
    >> Share

  723. SHREE HARINI K, Ezhilarasan D
    Promising autophagy inhibitors: Therapeutic implications in oral cancer.
    Oral Oncol. 2022;131:105948.
    >> Share

  724. DE FELICE F
    FLASH radiotherapy in head and neck cancer: Myth or reality?
    Oral Oncol. 2022;131:105953.
    >> Share

  725. VIJAYASHREE PRIYADHARSINI J, Anitha P
    Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions.
    Oral Oncol. 2022;129:105902.
    >> Share

  726. LEBOUCHER A, Sotton S, Gambin Flandrin I, Magne N, et al
    Head and neck radiotherapy-induced carotid toxicity: Pathophysiological concepts and clinical syndromes.
    Oral Oncol. 2022;129:105868.
    >> Share

  727. BALACHANDER K, Paramasivam A
    Mitophagy: A therapeutic target for oral squamous cell carcinoma.
    Oral Oncol. 2022;129:105881.
    >> Share

  728. FERRELI F, Pirola F, Di Santo D, De Virgilio A, et al
    A critical analysis of the classifications of squamous cell carcinoma of the nasal vestibule.
    Oral Oncol. 2022;129:105880.
    >> Share

  729. PAQUIN R, Gill B, Martin E, Byrd JK, et al
    Base of tongue neuroendocrine carcinoma: A case report.
    Oral Oncol. 2022;129:105780.
    >> Share

    May 2022
  730. JAYARAMAN S, Pazhani J, PriyaVeeraraghavan V, Raj AT, et al
    PCNA and Ki67: Prognostic proliferation markers for oral cancer.
    Oral Oncol. 2022;130:105943.
    >> Share

  731. BALACHANDER K, Paramasivam A
    Selective autophagy as a potential therapeutic target for oral cancer.
    Oral Oncol. 2022;130:105934.
    >> Share

  732. PATIL VM, Kolkur M, Kumar Chinthala S, Waratkar G, et al
    Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.
    Oral Oncol. 2022;130:105908.
    >> Share

  733. UEDA Y, Okano S, Enokida T, Fujisawa T, et al
    Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
    Oral Oncol. 2022;130:105932.
    >> Share

  734. WARNER L, O'Hara JT, Lin DJ, Oozeer N, et al
    Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Oral Oncol. 2022;130:105909.
    >> Share

  735. VARGHESE BT, Shivanesan P
    Anatomical distortion of the right recurrent laryngeal nerve in level 7 neck dissection.
    Oral Oncol. 2022;130:105929.
    >> Share

  736. SMILINE GIRIJA AS
    Natural "epidrugs" and the need of basket trials in the treatment of oral cancer in India.
    Oral Oncol. 2022;130:105931.
    >> Share

  737. SHIAO JC, Holt D, Ladbury C, Gao D, et al
    The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;130:105907.
    >> Share

  738. LOW SK, Reed CT, Millo C, Turkbey EB, et al
    Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.
    Oral Oncol. 2022;130:105928.
    >> Share

  739. PARAMASIVAM A
    Plasma circulating tumor DNA as a molecular marker for oral cancer.
    Oral Oncol. 2022;130:105926.
    >> Share

  740. SELVARAJ J, Yasothkumar D, Vishnu Priya V, Raj AT, et al
    Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105922.
    >> Share

  741. YANG X, Song H, Ji T, Du G, et al
    The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Oral Oncol. 2022;130:105924.
    >> Share

  742. FORNER D, Mok F, Verma N, Karam I, et al
    Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
    Oral Oncol. 2022;130:105903.
    >> Share

  743. PAZHANI J, Jayaraman S, Veeraraghavan VP, Somasundaram DB, et al
    Targeting cancer associated fibroblasts - A TGF-beta based immunotherapy for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105899.
    >> Share

  744. JIANG Y, Yang S, Qi Y
    Comment on: The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2022;130:105872.
    >> Share

  745. MADY LJ, Baddour K, Hodges JC, Magana LC, et al
    Corrigendum to "The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm" [Oral Oncol. 126 (2022) 105766].
    Oral Oncol. 2022 May 2:105882. doi: 10.1016/j.oraloncology.2022.105882.
    >> Share

  746. SWARTZ JE, Smits HJG, Philippens MEP, de Bree R, et al
    Correlation and colocalization of HIF-1alpha and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
    Oral Oncol. 2022;128:105862.
    >> Share

  747. YEOM S, Jung EK, Lee DH, Lee JK, et al
    Clinical features and recurrence factors of benign neoplasms of the tongue base.
    Oral Oncol. 2022;128:105866.
    >> Share

  748. COUTU B, Ryan E, Christensen D, Lawrence E, et al
    Positive margins matter regardless of subsequent resection findings.
    Oral Oncol. 2022;128:105850.
    >> Share

  749. MULLER RG, Hamill CS, Vu B, Thuener J, et al
    Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2022;128:105861.
    >> Share

  750. MOLNAR K, Hietanen S, Liisanantti J, Koivunen P, et al
    Quality of life after free flap reconstruction for the cancer of the head and neck: Comparison between five-year survivors and non-survivors.
    Oral Oncol. 2022;128:105855.
    >> Share

  751. TRANCHITO E, Cabrera C, Terry M, Li S, et al
    Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database.
    Oral Oncol. 2022;128:105829.
    >> Share

  752. WEN X, Hu Y, Liu Y, Li Z, et al
    Conservative treatment of head and neck lymphoma is not the only effective treatment: A retrospective analysis of 301 cases.
    Oral Oncol. 2022;128:105828.
    >> Share

    April 2022
  753. GALLOGLY JA JR, Weber AK, Mazul AL, Brinkmeier JV, et al
    Inferior outcomes associated with emergency department presentation for head and neck cancer surgery.
    Oral Oncol. 2022;129:105894.
    >> Share

  754. SHE L, Tian K, Han J, Zuo W, et al
    Pembrolizumab with or without chemotherapy versus cetuximab plus chemotherapy to treat recurrent or metastatic head and neck squamous cell carcinoma: An updated KEYNOTE-048 based cost-effectiveness analysis.
    Oral Oncol. 2022;129:105871.
    >> Share

  755. KATO A, Matsuda Y, Morioka R, Okui T, et al
    Discrepancy between subjective and objective postoperative oral dysfunction assessment after oral cancer treatment: A single-center cross-sectional study.
    Oral Oncol. 2022;129:105879.
    >> Share

  756. HAIST C, Poschinski Z, Bister A, Hoffmann MJ, et al
    Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas.
    Oral Oncol. 2022;129:105867.
    >> Share

  757. SEKAR D, Panagal M, Manimaran D, Ahmad N, et al
    miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer.
    Oral Oncol. 2022;129:105873.
    >> Share

  758. LIU T, Ma L, Song L, Yan B, et al
    CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;129:105858.
    >> Share

  759. NERALLA M, Senthilnthan P, Kubendiran D, Nandan A, et al
    Dry needle therapy for post operative shoulder dysfunction in oral cancer patients.
    Oral Oncol. 2022;128:105865.
    >> Share

  760. PETRELLI F, Trevisan F, Ghidini A, Capriotti V, et al
    Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis.
    Oral Oncol. 2022;128:105864.
    >> Share

  761. ZHOU S, Chan C, Rulach R, Dyab H, et al
    Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
    Oral Oncol. 2022;128:105870.
    >> Share

  762. YANG ZC, Nie ZQ, Chen QY, Du CC, et al
    Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.
    Oral Oncol. 2022;128:105851.
    >> Share

  763. FENG G, Feng H, Qi Y, Wang T, et al
    Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer.
    Oral Oncol. 2022;128:105859.
    >> Share

  764. CHEN Y, Zheng X, Lin J, Gao X, et al
    A high homologous recombination deficiency score is associated with poor survival and a non-inflamed tumor microenvironment in head and neck squamous cell carcinoma patients.
    Oral Oncol. 2022;128:105860.
    >> Share

  765. TIAN K, Han J, Wang Z, Chen J, et al
    Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis.
    Oral Oncol. 2022;128:105842.
    >> Share

  766. BALACHANDER K, Roy A, Priyadharsini JV, Murugan S, et al
    Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer.
    Oral Oncol. 2022;128:105857.
    >> Share

  767. DE LA COUR CD, Munk C, Aalborg GL, Kjaer SK, et al
    Base of tongue/tonsillar and laryngeal cancer in Denmark 1994-2018: Temporal trends in incidence according to education and age.
    Oral Oncol. 2022;128:105832.
    >> Share

  768. BANERJEE A, Misra SR, Roy B, Singh S, et al
    Central oral histopathology registry (COHR) - A proposal promising hope for oral cancer and oral pathology research.
    Oral Oncol. 2022;128:105856.
    >> Share

  769. SEKAR D, Murthykumar K, Ganapathy D
    miR-206 and its mimics: A predictive biomarker and therapeutic molecule in the treatment of oral cancer.
    Oral Oncol. 2022;128:105849.
    >> Share

  770. RISCHIN D, Harrington KJ, Greil R, Soulieres D, et al
    Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Oral Oncol. 2022;128:105815.
    >> Share

  771. VAIDYA K, Sarode SC, Gadre P, Gadre K, et al
    Mammary analogue secretory carcinoma presenting as localized hematoma of the palate.
    Oral Oncol. 2022;127:105821.
    >> Share

  772. BIJAI LK, Muthukrishnan A
    Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
    Oral Oncol. 2022;127:105810.
    >> Share

  773. NAMRATA D, Lakshmi T, Rushabh D, Ezhilarasan D, et al
    Role of stress management in oral malignant and premalignant conditions.
    Oral Oncol. 2022;127:105813.
    >> Share

  774. DE SOUZA GP, Santos MM, Ferreira IN, Cunha JLS, et al
    Oral basaloid squamous cell carcinoma: A case report with emphasis on histopathological diagnosis criteria.
    Oral Oncol. 2022;127:105814.
    >> Share

  775. SEKAR D
    Implications of long non-coding RNAs (lncRNAs) in the treatment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;127:105812.
    >> Share

  776. TANS L, Al-Mamgani A, Kwa SLS, Elbers JBW, et al
    Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile.
    Oral Oncol. 2022;127:105782.
    >> Share

  777. BRINKMAN D, Callanan D, Jawad H, O'Sullivan R, et al
    Comparison of royal college of pathologists and college of american pathologists definition for positive margins in oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;127:105797.
    >> Share

  778. ROH JL
    Gland-preserving surgery of benign parotid tumours via postauricular sulcus incision: Is it safe and effective with the scarless incision?
    Oral Oncol. 2022;127:105808.
    >> Share

  779. WANG SJ, Shen SY, Lin B, Wang F, et al
    Factors affecting postoperative sleep quality of patients undergoing flap transfer for head and neck reconstruction.
    Oral Oncol. 2022;127:105804.
    >> Share

  780. SARODE SC, Sarode GS, Sharma NK
    Salivary gland carcinomas and molecular chaos: Additional perspectives.
    Oral Oncol. 2022;127:105802.
    >> Share

  781. SEKAR D
    The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD).
    Oral Oncol. 2022;127:105786.
    >> Share

  782. LIN A, Helgeson ES, Treister NS, Schmidt BL, et al
    The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study.
    Oral Oncol. 2022;127:105783.
    >> Share

  783. COMER JC, King RB, Harris AB, Hitchcock KE, et al
    Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
    Oral Oncol. 2022;127:105767.
    >> Share

  784. YANG Q, Cheng C, Zhu R, Guo F, et al
    A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
    Oral Oncol. 2022;127:105771.
    >> Share

  785. EGAL ESA, Scarini JF, de Lima-Souza RA, Lavareze L, et al
    Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.
    Oral Oncol. 2022;127:105777.
    >> Share

  786. DODDAWAD VG, Premalatha BR, Sreeshyla HS, Nitin P, et al
    Classification staging systems on clinical and radiographic features of inverted sinonasal papilloma: A case report.
    Oral Oncol. 2022;127:105768.
    >> Share

    March 2022
  787. PATIL V, Noronha V, Joshi A, Menon N, et al
    RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
    Oral Oncol. 2022;128:105816.
    >> Share

  788. CHANG CT, Liu SP, Muo CH, Liao YF, et al
    The impact of dental therapy timelines and irradiation dosages on osteoradionecrosis in oral cancer patients: A population-based cohort study.
    Oral Oncol. 2022;128:105827.
    >> Share

  789. HSIEH MC, Wang CC, Yang CC, Lien CF, et al
    The role of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma: A nationwide population-based matched study.
    Oral Oncol. 2022;128:105848.
    >> Share

  790. YANG X, Xu X, Zhang C, Ji T, et al
    The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
    Oral Oncol. 2022;128:105846.
    >> Share

  791. RANJAN MISRA S, Das R
    Tele-screening for early detection of oral cancer during the COVID-19 pandemic era: Diagnostic pitfalls and potential misinterpretations!
    Oral Oncol. 2022;128:105845.
    >> Share

  792. MATTOX AK, D'Souza G, Khan Z, Allen H, et al
    Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Oral Oncol. 2022;128:105805.
    >> Share

  793. BALACHANDER K, Paramasivam A
    Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer.
    Oral Oncol. 2022;127:105825.
    >> Share

  794. YAMAGUMA Y, Kaneuji T, Shirouzu S, Fukui T, et al
    Combination therapy of Mohs paste and chemotherapy improved metastatic oral cancer to the precordium skin and bilateral axillary lymph nodes: A case report.
    Oral Oncol. 2022;127:105817.
    >> Share

  795. VILLARD A, Breuskin I, Casiraghi O, Asmandar S, et al
    Confocal laser endomicroscopy and confocal microscopy for head and neck cancer imaging: Recent updates and future perspectives.
    Oral Oncol. 2022;127:105826.
    >> Share

  796. PATIL V, Alone M, Rai R, Noronha V, et al
    Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers.
    Oral Oncol. 2022;127:105824.
    >> Share

  797. DE LUCA P, Di Stadio A, Tassone D, de Campora L, et al
    Large cervical mass and head and neck cancer. First report of ectopic papillary adenoma of the lung.
    Oral Oncol. 2022;127:105823.
    >> Share

  798. DEVARAJA K, Kabekkodu SP
    Oral microbiome; a potential game-changer in the management of oral cancer?
    Oral Oncol. 2022;127:105822.
    >> Share

  799. BONETTI VALENTE V, Mantovan Mazzon B, Urbano Collado F, Conrado Neto S, et al
    Clinicopathological and prognostic profile of non-smoking and non-drinking head and neck cancer patients: a population-based comparative study.
    Oral Oncol. 2022;127:105799.
    >> Share

  800. SHETH S, Gilbert J, Deal AM, Chera B, et al
    Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105807.
    >> Share

  801. VALERO C, Yuan A, Zanoni DK, Lei E, et al
    Young non-smokers with oral cancer: What are we missing and why?
    Oral Oncol. 2022;127:105803.
    >> Share

  802. ELUMALAI P, Ezhilarasan D, Lakshmi T
    Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach.
    Oral Oncol. 2022;127:105801.
    >> Share

  803. GLAZAR DJ, Johnson M, Farinhas J, Steuer CE, et al
    Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab.
    Oral Oncol. 2022;127:105787.
    >> Share

  804. ROUTILA J, Qiao X, Weltner J, Rantala JK, et al
    Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105772.
    >> Share

  805. BRODY RM, Shimunov D, Cohen RB, Lin A, et al
    A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
    Oral Oncol. 2022;127:105798.
    >> Share

  806. GONCALVES JM, Scarini JF, Gondak R, Altemani A, et al
    Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
    Oral Oncol. 2022;126:105779.
    >> Share

  807. I GHANEM A, Woody NM, Schymick MA, Joshi NP, et al
    Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.
    Oral Oncol. 2022;126:105781.
    >> Share

  808. LOMBARDI D, Tomasoni M, Lorini L, Gurizzan C, et al
    Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;126:105764.
    >> Share

  809. CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
    The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations.
    Oral Oncol. 2022;126:105751.
    >> Share

  810. AL-LAMI A, Gao C, Saddiq M, Al Zuhir N, et al
    Reducing the unknowns: A systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary.
    Oral Oncol. 2022;126:105748.
    >> Share

  811. SEKAR D
    Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;126:105763.
    >> Share

  812. SILVA LC, Faustino ISP, Cantadori GR, Santos-Silva AR, et al
    Adenocarcinoma not otherwise specified (NOS) arising in the sublingual gland: Rare case report and follow-up.
    Oral Oncol. 2022;126:105754.
    >> Share

  813. KANG CJ, Wen YW, Lee SR, Ng SH, et al
    Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Oral Oncol. 2022;126:105750.
    >> Share

  814. SAKTHIVEL P, Raveendran S, Rajeshwari M
    Sinonasal small round blue cell tumors: What the clinician must know!
    Oral Oncol. 2022;126:105735.
    >> Share

  815. YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
    Clinical trial outcomes in oral squamous cell carcinoma: A pragmatic ideation.
    Oral Oncol. 2022;126:105752.
    >> Share

  816. CHAGAS-NETO JL, Nogueira DPS, Santos-Neto AGD, Duarte IX, et al
    Hyalinizing clear cell carcinoma of minor salivary glands: A case report with uncommon presentation.
    Oral Oncol. 2022;126:105753.
    >> Share

  817. E C, M D, K C, V A, et al
    Trismus therapy devices: A systematic review.
    Oral Oncol. 2022;126:105728.
    >> Share

  818. NAYYAR V, Bhutia O, Kakkar A, Mishra D, et al
    Primary intraosseous oncocytic mucoepidermoid carcinoma of the jaw: First case report.
    Oral Oncol. 2022;126:105732.
    >> Share

  819. RAMOS-GARCIA P, Gonzalez-Moles MA, Warnakulasuriya S
    Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.
    Oral Oncol. 2022;126:105734.
    >> Share

    February 2022
  820. QURESHI HA, Zhu X, Yang GH, Steadele M, et al
    Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105774.
    >> Share

  821. BELGIOIA L, Becherini C, Bacigalupo A, Bonomo P, et al
    Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
    Oral Oncol. 2022;127:105773.
    >> Share

  822. DAGLINAMRATA, Lakshmi T, Rushabh D, Dineshkumar T, et al
    Telescreening as an alternate modality for early detection of oral cancer.
    Oral Oncol. 2022;127:105785.
    >> Share

  823. HARING CT, Dermody SM, Yalamanchi P, Kang SY, et al
    The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;126:105776.
    >> Share

  824. MICHMERHUIZEN NL, Heenan C, Wang J, Leonard E, et al
    Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model.
    Oral Oncol. 2022;126:105770.
    >> Share

  825. MADY LJ, Baddour K, Hodges JC, Magana LC, et al
    The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm.
    Oral Oncol. 2022;126:105766.
    >> Share

  826. ZHANG S, Zhang W, Zhang J
    Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;126:105755.
    >> Share

  827. LI JL, Hsieh TL, Ou MC, Lin FC, et al
    Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients.
    Oral Oncol. 2022;126:105729.
    >> Share

  828. LENOCI D, Carenzo A, Cavalieri S, Pistore F, et al
    Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
    Oral Oncol. 2022;126:105756.
    >> Share

  829. CHAN SK, Lin C, Huang SH, Chau TC, et al
    Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
    Oral Oncol. 2022;126:105736.
    >> Share

  830. VAN MUNSTER MH, de Bree R, Breimer GE, Van Cann EM, et al
    Surgical margins in the resection of oral squamous cell carcinoma under local versus general anesthesia.
    Oral Oncol. 2022;125:105724.
    >> Share

  831. KRISHNA A, Singh S, Kumar V
    Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
    Oral Oncol. 2022;125:105720.
    >> Share

  832. SILVERMAN DA, Parikh AS, Liu K, Zhan KY, et al
    Predictors of survival following carotid blowout syndrome.
    Oral Oncol. 2022;125:105723.
    >> Share

  833. ZOTTI F, Nocini R, Capocasale G, Fior A, et al
    Response to a Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence".
    Oral Oncol. 2022;125:105714.
    >> Share

  834. TEZ M
    Chronic mechanical irritation and oral squamous cell carcinoma: Let's look from evolutionary perspective.
    Oral Oncol. 2022;125:105727.
    >> Share

  835. GANAPATHY D, Ramadoss R, Yuwanati M, Karthikeyan M, et al
    Rarity of mucormycosis in oral squamous cell carcinoma: A clinical paradox?
    Oral Oncol. 2022;125:105725.
    >> Share

  836. CHIN O, Alshafai L, O'Sullivan B, Su J, et al
    Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.
    Oral Oncol. 2022;125:105716.
    >> Share

  837. FAUSTINO ISP, Georgaki M, Santos-Silva AR, Vargas PA, et al
    Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis.
    Oral Oncol. 2022;125:105710.
    >> Share

  838. MENDEZ AI, Wihlidal JGJ, Eurich DT, Nichols AC, et al
    Validity of functional patient-reported outcomes in head and neck oncology: A systematic review.
    Oral Oncol. 2022;125:105701.
    >> Share

  839. SARODE G, Sarode SC, Sharma NK
    Phenotypic reflection of white sponge nevus in histomorphological features of oral squamous cell carcinoma.
    Oral Oncol. 2022;125:105707.
    >> Share

  840. MISRA SR, Mishra N, Satpathy SK
    Primary oral melanoma: ABCDE or AEIOU criteria for clinical diagnosis?
    Oral Oncol. 2022;125:105706.
    >> Share

  841. VAN WEERT S, Valstar M, Lissenberg-Witte B, Bloemena E, et al
    Prognostic factors in acinic cell carcinoma of the head and neck: The Amsterdam experience.
    Oral Oncol. 2022;125:105698.
    >> Share

  842. CHEN TC, Wang C, Su LY, Lin MC, et al
    Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;125:105683.
    >> Share

  843. SAWHNEY S, Thiagarajan S, Balaji A, Sathe P, et al
    Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.
    Oral Oncol. 2022;125:105684.
    >> Share

  844. FERREIRA PS, Rocha L, Bezerra APC, Nico MMS, et al
    Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.
    Oral Oncol. 2022;125:105674.
    >> Share